TW201945515A - 雜芳族化合物及使用該雜芳族化合物的有機電激發光組件 - Google Patents
雜芳族化合物及使用該雜芳族化合物的有機電激發光組件 Download PDFInfo
- Publication number
- TW201945515A TW201945515A TW108114203A TW108114203A TW201945515A TW 201945515 A TW201945515 A TW 201945515A TW 108114203 A TW108114203 A TW 108114203A TW 108114203 A TW108114203 A TW 108114203A TW 201945515 A TW201945515 A TW 201945515A
- Authority
- TW
- Taiwan
- Prior art keywords
- compound
- substituted
- unsubstituted
- carbon atoms
- group
- Prior art date
Links
- 150000002390 heteroarenes Chemical class 0.000 title claims abstract description 40
- 238000005401 electroluminescence Methods 0.000 title abstract 3
- 239000000463 material Substances 0.000 claims abstract description 19
- 150000001875 compounds Chemical class 0.000 claims description 473
- 125000004432 carbon atom Chemical group C* 0.000 claims description 86
- -1 carbon atoms Amine Chemical class 0.000 claims description 73
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 37
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 21
- 239000000126 substance Substances 0.000 claims description 20
- 125000000217 alkyl group Chemical group 0.000 claims description 19
- 229910052717 sulfur Inorganic materials 0.000 claims description 19
- 125000003118 aryl group Chemical group 0.000 claims description 18
- 229910052760 oxygen Inorganic materials 0.000 claims description 17
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 14
- 125000001072 heteroaryl group Chemical group 0.000 claims description 14
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 14
- 229910052736 halogen Inorganic materials 0.000 claims description 12
- 150000002367 halogens Chemical class 0.000 claims description 12
- 125000005264 aryl amine group Chemical group 0.000 claims description 9
- 125000001624 naphthyl group Chemical group 0.000 claims description 9
- 239000010409 thin film Substances 0.000 claims description 9
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 claims description 6
- 229910052741 iridium Inorganic materials 0.000 claims description 4
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 claims description 4
- IWZSHWBGHQBIML-ZGGLMWTQSA-N (3S,8S,10R,13S,14S,17S)-17-isoquinolin-7-yl-N,N,10,13-tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine Chemical compound CN(C)[C@H]1CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC[C@@H]4c4ccc5ccncc5c4)[C@@H]3CC=C2C1 IWZSHWBGHQBIML-ZGGLMWTQSA-N 0.000 claims description 3
- 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 claims description 3
- 229940125782 compound 2 Drugs 0.000 claims description 3
- 229940126214 compound 3 Drugs 0.000 claims description 3
- 125000004988 dibenzothienyl group Chemical group C1(=CC=CC=2SC3=C(C21)C=CC=C3)* 0.000 claims description 3
- ASGMFNBUXDJWJJ-JLCFBVMHSA-N (1R,3R)-3-[[3-bromo-1-[4-(5-methyl-1,3,4-thiadiazol-2-yl)phenyl]pyrazolo[3,4-d]pyrimidin-6-yl]amino]-N,1-dimethylcyclopentane-1-carboxamide Chemical compound BrC1=NN(C2=NC(=NC=C21)N[C@H]1C[C@@](CC1)(C(=O)NC)C)C1=CC=C(C=C1)C=1SC(=NN=1)C ASGMFNBUXDJWJJ-JLCFBVMHSA-N 0.000 claims description 2
- UAOUIVVJBYDFKD-XKCDOFEDSA-N (1R,9R,10S,11R,12R,15S,18S,21R)-10,11,21-trihydroxy-8,8-dimethyl-14-methylidene-4-(prop-2-enylamino)-20-oxa-5-thia-3-azahexacyclo[9.7.2.112,15.01,9.02,6.012,18]henicosa-2(6),3-dien-13-one Chemical compound C([C@@H]1[C@@H](O)[C@@]23C(C1=C)=O)C[C@H]2[C@]12C(N=C(NCC=C)S4)=C4CC(C)(C)[C@H]1[C@H](O)[C@]3(O)OC2 UAOUIVVJBYDFKD-XKCDOFEDSA-N 0.000 claims description 2
- AOSZTAHDEDLTLQ-AZKQZHLXSA-N (1S,2S,4R,8S,9S,11S,12R,13S,19S)-6-[(3-chlorophenyl)methyl]-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one Chemical compound C([C@@H]1C[C@H]2[C@H]3[C@]([C@]4(C=CC(=O)C=C4[C@@H](F)C3)C)(F)[C@@H](O)C[C@@]2([C@@]1(C1)C(=O)CO)C)N1CC1=CC=CC(Cl)=C1 AOSZTAHDEDLTLQ-AZKQZHLXSA-N 0.000 claims description 2
- ABJSOROVZZKJGI-OCYUSGCXSA-N (1r,2r,4r)-2-(4-bromophenyl)-n-[(4-chlorophenyl)-(2-fluoropyridin-4-yl)methyl]-4-morpholin-4-ylcyclohexane-1-carboxamide Chemical compound C1=NC(F)=CC(C(NC(=O)[C@H]2[C@@H](C[C@@H](CC2)N2CCOCC2)C=2C=CC(Br)=CC=2)C=2C=CC(Cl)=CC=2)=C1 ABJSOROVZZKJGI-OCYUSGCXSA-N 0.000 claims description 2
- SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 claims description 2
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 claims description 2
- GCTFTMWXZFLTRR-GFCCVEGCSA-N (2r)-2-amino-n-[3-(difluoromethoxy)-4-(1,3-oxazol-5-yl)phenyl]-4-methylpentanamide Chemical compound FC(F)OC1=CC(NC(=O)[C@H](N)CC(C)C)=CC=C1C1=CN=CO1 GCTFTMWXZFLTRR-GFCCVEGCSA-N 0.000 claims description 2
- IUSARDYWEPUTPN-OZBXUNDUSA-N (2r)-n-[(2s,3r)-4-[[(4s)-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-3-hydroxy-1-[3-(1,3-thiazol-2-yl)phenyl]butan-2-yl]-2-methoxypropanamide Chemical compound C([C@H](NC(=O)[C@@H](C)OC)[C@H](O)CN[C@@H]1C2=CC(CC(C)(C)C)=CN=C2OC2(CCC2)C1)C(C=1)=CC=CC=1C1=NC=CS1 IUSARDYWEPUTPN-OZBXUNDUSA-N 0.000 claims description 2
- YJLIKUSWRSEPSM-WGQQHEPDSA-N (2r,3r,4s,5r)-2-[6-amino-8-[(4-phenylphenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1CNC1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O YJLIKUSWRSEPSM-WGQQHEPDSA-N 0.000 claims description 2
- WWTBZEKOSBFBEM-SPWPXUSOSA-N (2s)-2-[[2-benzyl-3-[hydroxy-[(1r)-2-phenyl-1-(phenylmethoxycarbonylamino)ethyl]phosphoryl]propanoyl]amino]-3-(1h-indol-3-yl)propanoic acid Chemical compound N([C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)O)C(=O)C(CP(O)(=O)[C@H](CC=1C=CC=CC=1)NC(=O)OCC=1C=CC=CC=1)CC1=CC=CC=C1 WWTBZEKOSBFBEM-SPWPXUSOSA-N 0.000 claims description 2
- STBLNCCBQMHSRC-BATDWUPUSA-N (2s)-n-[(3s,4s)-5-acetyl-7-cyano-4-methyl-1-[(2-methylnaphthalen-1-yl)methyl]-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide Chemical compound O=C1[C@@H](NC(=O)[C@H](C)NC)[C@H](C)N(C(C)=O)C2=CC(C#N)=CC=C2N1CC1=C(C)C=CC2=CC=CC=C12 STBLNCCBQMHSRC-BATDWUPUSA-N 0.000 claims description 2
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 claims description 2
- UDQTXCHQKHIQMH-KYGLGHNPSA-N (3ar,5s,6s,7r,7ar)-5-(difluoromethyl)-2-(ethylamino)-5,6,7,7a-tetrahydro-3ah-pyrano[3,2-d][1,3]thiazole-6,7-diol Chemical compound S1C(NCC)=N[C@H]2[C@@H]1O[C@H](C(F)F)[C@@H](O)[C@@H]2O UDQTXCHQKHIQMH-KYGLGHNPSA-N 0.000 claims description 2
- OOKAZRDERJMRCJ-KOUAFAAESA-N (3r)-7-[(1s,2s,4ar,6s,8s)-2,6-dimethyl-8-[(2s)-2-methylbutanoyl]oxy-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]-3-hydroxy-5-oxoheptanoic acid Chemical compound C1=C[C@H](C)[C@H](CCC(=O)C[C@@H](O)CC(O)=O)C2[C@@H](OC(=O)[C@@H](C)CC)C[C@@H](C)C[C@@H]21 OOKAZRDERJMRCJ-KOUAFAAESA-N 0.000 claims description 2
- HUWSZNZAROKDRZ-RRLWZMAJSA-N (3r,4r)-3-azaniumyl-5-[[(2s,3r)-1-[(2s)-2,3-dicarboxypyrrolidin-1-yl]-3-methyl-1-oxopentan-2-yl]amino]-5-oxo-4-sulfanylpentane-1-sulfonate Chemical compound OS(=O)(=O)CC[C@@H](N)[C@@H](S)C(=O)N[C@@H]([C@H](C)CC)C(=O)N1CCC(C(O)=O)[C@H]1C(O)=O HUWSZNZAROKDRZ-RRLWZMAJSA-N 0.000 claims description 2
- YQOLEILXOBUDMU-KRWDZBQOSA-N (4R)-5-[(6-bromo-3-methyl-2-pyrrolidin-1-ylquinoline-4-carbonyl)amino]-4-(2-chlorophenyl)pentanoic acid Chemical compound CC1=C(C2=C(C=CC(=C2)Br)N=C1N3CCCC3)C(=O)NC[C@H](CCC(=O)O)C4=CC=CC=C4Cl YQOLEILXOBUDMU-KRWDZBQOSA-N 0.000 claims description 2
- VUEGYUOUAAVYAS-JGGQBBKZSA-N (6ar,9s,10ar)-9-(dimethylsulfamoylamino)-7-methyl-6,6a,8,9,10,10a-hexahydro-4h-indolo[4,3-fg]quinoline Chemical compound C1=CC([C@H]2C[C@@H](CN(C)[C@@H]2C2)NS(=O)(=O)N(C)C)=C3C2=CNC3=C1 VUEGYUOUAAVYAS-JGGQBBKZSA-N 0.000 claims description 2
- DEVSOMFAQLZNKR-RJRFIUFISA-N (z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-n'-pyrazin-2-ylprop-2-enehydrazide Chemical compound FC(F)(F)C1=CC(C(F)(F)F)=CC(C2=NN(\C=C/C(=O)NNC=3N=CC=NC=3)C=N2)=C1 DEVSOMFAQLZNKR-RJRFIUFISA-N 0.000 claims description 2
- KKHFRAFPESRGGD-UHFFFAOYSA-N 1,3-dimethyl-7-[3-(n-methylanilino)propyl]purine-2,6-dione Chemical compound C1=NC=2N(C)C(=O)N(C)C(=O)C=2N1CCCN(C)C1=CC=CC=C1 KKHFRAFPESRGGD-UHFFFAOYSA-N 0.000 claims description 2
- KQZLRWGGWXJPOS-NLFPWZOASA-N 1-[(1R)-1-(2,4-dichlorophenyl)ethyl]-6-[(4S,5R)-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-5-methylcyclohexen-1-yl]pyrazolo[3,4-b]pyrazine-3-carbonitrile Chemical compound ClC1=C(C=CC(=C1)Cl)[C@@H](C)N1N=C(C=2C1=NC(=CN=2)C1=CC[C@@H]([C@@H](C1)C)N1[C@@H](CCC1)CO)C#N KQZLRWGGWXJPOS-NLFPWZOASA-N 0.000 claims description 2
- WZZBNLYBHUDSHF-DHLKQENFSA-N 1-[(3s,4s)-4-[8-(2-chloro-4-pyrimidin-2-yloxyphenyl)-7-fluoro-2-methylimidazo[4,5-c]quinolin-1-yl]-3-fluoropiperidin-1-yl]-2-hydroxyethanone Chemical compound CC1=NC2=CN=C3C=C(F)C(C=4C(=CC(OC=5N=CC=CN=5)=CC=4)Cl)=CC3=C2N1[C@H]1CCN(C(=O)CO)C[C@@H]1F WZZBNLYBHUDSHF-DHLKQENFSA-N 0.000 claims description 2
- ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 claims description 2
- UNILWMWFPHPYOR-KXEYIPSPSA-M 1-[6-[2-[3-[3-[3-[2-[2-[3-[[2-[2-[[(2r)-1-[[2-[[(2r)-1-[3-[2-[2-[3-[[2-(2-amino-2-oxoethoxy)acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-[(2r)-2,3-di(hexadecanoyloxy)propyl]sulfanyl-1-oxopropan-2-yl Chemical compound O=C1C(SCCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CSC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)NCC(=O)N[C@H](CO)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)CC(=O)N1CCNC(=O)CCCCCN\1C2=CC=C(S([O-])(=O)=O)C=C2CC/1=C/C=C/C=C/C1=[N+](CC)C2=CC=C(S([O-])(=O)=O)C=C2C1 UNILWMWFPHPYOR-KXEYIPSPSA-M 0.000 claims description 2
- QXOGPTXQGKQSJT-UHFFFAOYSA-N 1-amino-4-[4-(3,4-dimethylphenyl)sulfanylanilino]-9,10-dioxoanthracene-2-sulfonic acid Chemical compound Cc1ccc(Sc2ccc(Nc3cc(c(N)c4C(=O)c5ccccc5C(=O)c34)S(O)(=O)=O)cc2)cc1C QXOGPTXQGKQSJT-UHFFFAOYSA-N 0.000 claims description 2
- WGFNXGPBPIJYLI-UHFFFAOYSA-N 2,6-difluoro-3-[(3-fluorophenyl)sulfonylamino]-n-(3-methoxy-1h-pyrazolo[3,4-b]pyridin-5-yl)benzamide Chemical compound C1=C2C(OC)=NNC2=NC=C1NC(=O)C(C=1F)=C(F)C=CC=1NS(=O)(=O)C1=CC=CC(F)=C1 WGFNXGPBPIJYLI-UHFFFAOYSA-N 0.000 claims description 2
- QEBYEVQKHRUYPE-UHFFFAOYSA-N 2-(2-chlorophenyl)-5-[(1-methylpyrazol-3-yl)methyl]-4-[[methyl(pyridin-3-ylmethyl)amino]methyl]-1h-pyrazolo[4,3-c]pyridine-3,6-dione Chemical compound C1=CN(C)N=C1CN1C(=O)C=C2NN(C=3C(=CC=CC=3)Cl)C(=O)C2=C1CN(C)CC1=CC=CN=C1 QEBYEVQKHRUYPE-UHFFFAOYSA-N 0.000 claims description 2
- PYRKKGOKRMZEIT-UHFFFAOYSA-N 2-[6-(2-cyclopropylethoxy)-9-(2-hydroxy-2-methylpropyl)-1h-phenanthro[9,10-d]imidazol-2-yl]-5-fluorobenzene-1,3-dicarbonitrile Chemical compound C1=C2C3=CC(CC(C)(O)C)=CC=C3C=3NC(C=4C(=CC(F)=CC=4C#N)C#N)=NC=3C2=CC=C1OCCC1CC1 PYRKKGOKRMZEIT-UHFFFAOYSA-N 0.000 claims description 2
- FMKGJQHNYMWDFJ-CVEARBPZSA-N 2-[[4-(2,2-difluoropropoxy)pyrimidin-5-yl]methylamino]-4-[[(1R,4S)-4-hydroxy-3,3-dimethylcyclohexyl]amino]pyrimidine-5-carbonitrile Chemical compound FC(COC1=NC=NC=C1CNC1=NC=C(C(=N1)N[C@H]1CC([C@H](CC1)O)(C)C)C#N)(C)F FMKGJQHNYMWDFJ-CVEARBPZSA-N 0.000 claims description 2
- PAYROHWFGZADBR-UHFFFAOYSA-N 2-[[4-amino-5-(5-iodo-4-methoxy-2-propan-2-ylphenoxy)pyrimidin-2-yl]amino]propane-1,3-diol Chemical compound C1=C(I)C(OC)=CC(C(C)C)=C1OC1=CN=C(NC(CO)CO)N=C1N PAYROHWFGZADBR-UHFFFAOYSA-N 0.000 claims description 2
- VVCMGAUPZIKYTH-VGHSCWAPSA-N 2-acetyloxybenzoic acid;[(2s,3r)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] propanoate;1,3,7-trimethylpurine-2,6-dione Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O.CN1C(=O)N(C)C(=O)C2=C1N=CN2C.C([C@](OC(=O)CC)([C@H](C)CN(C)C)C=1C=CC=CC=1)C1=CC=CC=C1 VVCMGAUPZIKYTH-VGHSCWAPSA-N 0.000 claims description 2
- YSUIQYOGTINQIN-UZFYAQMZSA-N 2-amino-9-[(1S,6R,8R,9S,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one Chemical compound NC1=NC2=C(N=CN2[C@@H]2O[C@@H]3COP(S)(=O)O[C@@H]4[C@@H](COP(S)(=O)O[C@@H]2[C@@H]3F)O[C@H]([C@H]4F)N2C=NC3=C2N=CN=C3N)C(=O)N1 YSUIQYOGTINQIN-UZFYAQMZSA-N 0.000 claims description 2
- TVTJUIAKQFIXCE-HUKYDQBMSA-N 2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynyl-1H-purine-6,8-dione Chemical compound NC=1NC(C=2N(C(N(C=2N=1)[C@@H]1O[C@@H]([C@H]([C@H]1O)F)CO)=O)CC#C)=O TVTJUIAKQFIXCE-HUKYDQBMSA-N 0.000 claims description 2
- NPRYCHLHHVWLQZ-TURQNECASA-N 2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynylpurin-8-one Chemical compound NC1=NC=C2N(C(N(C2=N1)[C@@H]1O[C@@H]([C@H]([C@H]1O)F)CO)=O)CC#C NPRYCHLHHVWLQZ-TURQNECASA-N 0.000 claims description 2
- DFRAKBCRUYUFNT-UHFFFAOYSA-N 3,8-dicyclohexyl-2,4,7,9-tetrahydro-[1,3]oxazino[5,6-h][1,3]benzoxazine Chemical compound C1CCCCC1N1CC(C=CC2=C3OCN(C2)C2CCCCC2)=C3OC1 DFRAKBCRUYUFNT-UHFFFAOYSA-N 0.000 claims description 2
- QBWKPGNFQQJGFY-QLFBSQMISA-N 3-[(1r)-1-[(2r,6s)-2,6-dimethylmorpholin-4-yl]ethyl]-n-[6-methyl-3-(1h-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine Chemical compound N1([C@H](C)C2=NSC(NC=3C4=NC=C(N4C=C(C)N=3)C3=CNN=C3)=C2)C[C@H](C)O[C@H](C)C1 QBWKPGNFQQJGFY-QLFBSQMISA-N 0.000 claims description 2
- MINMDCMSHDBHKG-UHFFFAOYSA-N 4-[4-[[6-methoxy-2-(2-methoxyimidazo[2,1-b][1,3,4]thiadiazol-6-yl)-1-benzofuran-4-yl]oxymethyl]-5-methyl-1,3-thiazol-2-yl]morpholine Chemical compound N1=C2SC(OC)=NN2C=C1C(OC1=CC(OC)=C2)=CC1=C2OCC(=C(S1)C)N=C1N1CCOCC1 MINMDCMSHDBHKG-UHFFFAOYSA-N 0.000 claims description 2
- VKLKXFOZNHEBSW-UHFFFAOYSA-N 5-[[3-[(4-morpholin-4-ylbenzoyl)amino]phenyl]methoxy]pyridine-3-carboxamide Chemical compound O1CCN(CC1)C1=CC=C(C(=O)NC=2C=C(COC=3C=NC=C(C(=O)N)C=3)C=CC=2)C=C1 VKLKXFOZNHEBSW-UHFFFAOYSA-N 0.000 claims description 2
- XFJBGINZIMNZBW-CRAIPNDOSA-N 5-chloro-2-[4-[(1r,2s)-2-[2-(5-methylsulfonylpyridin-2-yl)oxyethyl]cyclopropyl]piperidin-1-yl]pyrimidine Chemical compound N1=CC(S(=O)(=O)C)=CC=C1OCC[C@H]1[C@@H](C2CCN(CC2)C=2N=CC(Cl)=CN=2)C1 XFJBGINZIMNZBW-CRAIPNDOSA-N 0.000 claims description 2
- RSIWALKZYXPAGW-NSHDSACASA-N 6-(3-fluorophenyl)-3-methyl-7-[(1s)-1-(7h-purin-6-ylamino)ethyl]-[1,3]thiazolo[3,2-a]pyrimidin-5-one Chemical compound C=1([C@@H](NC=2C=3N=CNC=3N=CN=2)C)N=C2SC=C(C)N2C(=O)C=1C1=CC=CC(F)=C1 RSIWALKZYXPAGW-NSHDSACASA-N 0.000 claims description 2
- GDUANFXPOZTYKS-UHFFFAOYSA-N 6-bromo-8-[(2,6-difluoro-4-methoxybenzoyl)amino]-4-oxochromene-2-carboxylic acid Chemical compound FC1=CC(OC)=CC(F)=C1C(=O)NC1=CC(Br)=CC2=C1OC(C(O)=O)=CC2=O GDUANFXPOZTYKS-UHFFFAOYSA-N 0.000 claims description 2
- XASOHFCUIQARJT-UHFFFAOYSA-N 8-methoxy-6-[7-(2-morpholin-4-ylethoxy)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one Chemical compound C(N1C(=O)C2=C(OC)C=C(C=3N4C(=NC=3)C=C(C=C4)OCCN3CCOCC3)C=C2CC1)C(F)(F)F XASOHFCUIQARJT-UHFFFAOYSA-N 0.000 claims description 2
- IYHHRZBKXXKDDY-UHFFFAOYSA-N BI-605906 Chemical compound N=1C=2SC(C(N)=O)=C(N)C=2C(C(F)(F)CC)=CC=1N1CCC(S(C)(=O)=O)CC1 IYHHRZBKXXKDDY-UHFFFAOYSA-N 0.000 claims description 2
- JQUCWIWWWKZNCS-LESHARBVSA-N C(C1=CC=CC=C1)(=O)NC=1SC[C@H]2[C@@](N1)(CO[C@H](C2)C)C=2SC=C(N2)NC(=O)C2=NC=C(C=C2)OC(F)F Chemical compound C(C1=CC=CC=C1)(=O)NC=1SC[C@H]2[C@@](N1)(CO[C@H](C2)C)C=2SC=C(N2)NC(=O)C2=NC=C(C=C2)OC(F)F JQUCWIWWWKZNCS-LESHARBVSA-N 0.000 claims description 2
- OJRUSAPKCPIVBY-KQYNXXCUSA-N C1=NC2=C(N=C(N=C2N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(CP(=O)(O)O)O)O)O)I)N Chemical compound C1=NC2=C(N=C(N=C2N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(CP(=O)(O)O)O)O)O)I)N OJRUSAPKCPIVBY-KQYNXXCUSA-N 0.000 claims description 2
- UHNRLQRZRNKOKU-UHFFFAOYSA-N CCN(CC1=NC2=C(N1)C1=CC=C(C=C1N=C2N)C1=NNC=C1)C(C)=O Chemical compound CCN(CC1=NC2=C(N1)C1=CC=C(C=C1N=C2N)C1=NNC=C1)C(C)=O UHNRLQRZRNKOKU-UHFFFAOYSA-N 0.000 claims description 2
- SCJNYBYSTCRPAO-LXBQGUBHSA-N CN(C)C\C=C\C(=O)NC1=CC=C(N=C1)C(=O)N[C@@]1(C)CCC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1 Chemical compound CN(C)C\C=C\C(=O)NC1=CC=C(N=C1)C(=O)N[C@@]1(C)CCC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1 SCJNYBYSTCRPAO-LXBQGUBHSA-N 0.000 claims description 2
- PKMUHQIDVVOXHQ-HXUWFJFHSA-N C[C@H](C1=CC(C2=CC=C(CNC3CCCC3)S2)=CC=C1)NC(C1=C(C)C=CC(NC2CNC2)=C1)=O Chemical compound C[C@H](C1=CC(C2=CC=C(CNC3CCCC3)S2)=CC=C1)NC(C1=C(C)C=CC(NC2CNC2)=C1)=O PKMUHQIDVVOXHQ-HXUWFJFHSA-N 0.000 claims description 2
- 229940126657 Compound 17 Drugs 0.000 claims description 2
- 229940126639 Compound 33 Drugs 0.000 claims description 2
- 229940127007 Compound 39 Drugs 0.000 claims description 2
- LVDRREOUMKACNJ-BKMJKUGQSA-N N-[(2R,3S)-2-(4-chlorophenyl)-1-(1,4-dimethyl-2-oxoquinolin-7-yl)-6-oxopiperidin-3-yl]-2-methylpropane-1-sulfonamide Chemical compound CC(C)CS(=O)(=O)N[C@H]1CCC(=O)N([C@@H]1c1ccc(Cl)cc1)c1ccc2c(C)cc(=O)n(C)c2c1 LVDRREOUMKACNJ-BKMJKUGQSA-N 0.000 claims description 2
- AVYVHIKSFXVDBG-UHFFFAOYSA-N N-benzyl-N-hydroxy-2,2-dimethylbutanamide Chemical compound C(C1=CC=CC=C1)N(C(C(CC)(C)C)=O)O AVYVHIKSFXVDBG-UHFFFAOYSA-N 0.000 claims description 2
- POFVJRKJJBFPII-UHFFFAOYSA-N N-cyclopentyl-5-[2-[[5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl]amino]-5-fluoropyrimidin-4-yl]-4-methyl-1,3-thiazol-2-amine Chemical compound C1(CCCC1)NC=1SC(=C(N=1)C)C1=NC(=NC=C1F)NC1=NC=C(C=C1)CN1CCN(CC1)CC POFVJRKJJBFPII-UHFFFAOYSA-N 0.000 claims description 2
- OPFJDXRVMFKJJO-ZHHKINOHSA-N N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2 Chemical compound S1C(C=2NN=C(C=2)C(=O)NCC(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(N)=O)=C(C)N=C1NC(=O)C1=CC=CC=C1 OPFJDXRVMFKJJO-ZHHKINOHSA-N 0.000 claims description 2
- QOVYHDHLFPKQQG-NDEPHWFRSA-N N[C@@H](CCC(=O)N1CCC(CC1)NC1=C2C=CC=CC2=NC(NCC2=CN(CCCNCCCNC3CCCCC3)N=N2)=N1)C(O)=O Chemical compound N[C@@H](CCC(=O)N1CCC(CC1)NC1=C2C=CC=CC2=NC(NCC2=CN(CCCNCCCNC3CCCCC3)N=N2)=N1)C(O)=O QOVYHDHLFPKQQG-NDEPHWFRSA-N 0.000 claims description 2
- PNUZDKCDAWUEGK-CYZMBNFOSA-N Sitafloxacin Chemical compound C([C@H]1N)N(C=2C(=C3C(C(C(C(O)=O)=CN3[C@H]3[C@H](C3)F)=O)=CC=2F)Cl)CC11CC1 PNUZDKCDAWUEGK-CYZMBNFOSA-N 0.000 claims description 2
- SLGBZMMZGDRARJ-UHFFFAOYSA-N Triphenylene Natural products C1=CC=C2C3=CC=CC=C3C3=CC=CC=C3C2=C1 SLGBZMMZGDRARJ-UHFFFAOYSA-N 0.000 claims description 2
- LJOOWESTVASNOG-UFJKPHDISA-N [(1s,3r,4ar,7s,8s,8as)-3-hydroxy-8-[2-[(4r)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl] (2s)-2-methylbutanoate Chemical compound C([C@H]1[C@@H](C)C=C[C@H]2C[C@@H](O)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)CC1C[C@@H](O)CC(=O)O1 LJOOWESTVASNOG-UFJKPHDISA-N 0.000 claims description 2
- LNUFLCYMSVYYNW-ZPJMAFJPSA-N [(2r,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[[(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-disulfo Chemical compound O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O LNUFLCYMSVYYNW-ZPJMAFJPSA-N 0.000 claims description 2
- PSLUFJFHTBIXMW-WYEYVKMPSA-N [(3r,4ar,5s,6s,6as,10s,10ar,10bs)-3-ethenyl-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-6-(2-pyridin-2-ylethylcarbamoyloxy)-5,6,6a,8,9,10-hexahydro-2h-benzo[f]chromen-5-yl] acetate Chemical compound O([C@@H]1[C@@H]([C@]2(O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@@H]21)C=C)C)OC(=O)C)C(=O)NCCC1=CC=CC=N1 PSLUFJFHTBIXMW-WYEYVKMPSA-N 0.000 claims description 2
- SMNRFWMNPDABKZ-WVALLCKVSA-N [[(2R,3S,4R,5S)-5-(2,6-dioxo-3H-pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [[[(2R,3S,4S,5R,6R)-4-fluoro-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] hydrogen phosphate Chemical compound OC[C@H]1O[C@H](OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)C2C=CC(=O)NC2=O)[C@H](O)[C@@H](F)[C@@H]1O SMNRFWMNPDABKZ-WVALLCKVSA-N 0.000 claims description 2
- 150000004982 aromatic amines Chemical class 0.000 claims description 2
- XRWSZZJLZRKHHD-WVWIJVSJSA-N asunaprevir Chemical compound O=C([C@@H]1C[C@H](CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)OC1=NC=C(C2=CC=C(Cl)C=C21)OC)N[C@]1(C(=O)NS(=O)(=O)C2CC2)C[C@H]1C=C XRWSZZJLZRKHHD-WVWIJVSJSA-N 0.000 claims description 2
- KGNDCEVUMONOKF-UGPLYTSKSA-N benzyl n-[(2r)-1-[(2s,4r)-2-[[(2s)-6-amino-1-(1,3-benzoxazol-2-yl)-1,1-dihydroxyhexan-2-yl]carbamoyl]-4-[(4-methylphenyl)methoxy]pyrrolidin-1-yl]-1-oxo-4-phenylbutan-2-yl]carbamate Chemical compound C1=CC(C)=CC=C1CO[C@H]1CN(C(=O)[C@@H](CCC=2C=CC=CC=2)NC(=O)OCC=2C=CC=CC=2)[C@H](C(=O)N[C@@H](CCCCN)C(O)(O)C=2OC3=CC=CC=C3N=2)C1 KGNDCEVUMONOKF-UGPLYTSKSA-N 0.000 claims description 2
- 229940125904 compound 1 Drugs 0.000 claims description 2
- 229940125773 compound 10 Drugs 0.000 claims description 2
- 229940125797 compound 12 Drugs 0.000 claims description 2
- 229940126543 compound 14 Drugs 0.000 claims description 2
- 229940125758 compound 15 Drugs 0.000 claims description 2
- 229940126142 compound 16 Drugs 0.000 claims description 2
- 229940125810 compound 20 Drugs 0.000 claims description 2
- 229940126086 compound 21 Drugs 0.000 claims description 2
- 229940126208 compound 22 Drugs 0.000 claims description 2
- 229940125833 compound 23 Drugs 0.000 claims description 2
- 229940125961 compound 24 Drugs 0.000 claims description 2
- 229940125846 compound 25 Drugs 0.000 claims description 2
- 229940125851 compound 27 Drugs 0.000 claims description 2
- 229940127204 compound 29 Drugs 0.000 claims description 2
- 229940125877 compound 31 Drugs 0.000 claims description 2
- 229940125878 compound 36 Drugs 0.000 claims description 2
- 229940125807 compound 37 Drugs 0.000 claims description 2
- 229940127573 compound 38 Drugs 0.000 claims description 2
- 229940126540 compound 41 Drugs 0.000 claims description 2
- 229940125936 compound 42 Drugs 0.000 claims description 2
- 229940125844 compound 46 Drugs 0.000 claims description 2
- 229940127271 compound 49 Drugs 0.000 claims description 2
- 229940125898 compound 5 Drugs 0.000 claims description 2
- 229940126545 compound 53 Drugs 0.000 claims description 2
- 229940127113 compound 57 Drugs 0.000 claims description 2
- 229940125900 compound 59 Drugs 0.000 claims description 2
- 229940126179 compound 72 Drugs 0.000 claims description 2
- JPGQOUSTVILISH-UHFFFAOYSA-N enflurane Chemical compound FC(F)OC(F)(F)C(F)Cl JPGQOUSTVILISH-UHFFFAOYSA-N 0.000 claims description 2
- GWNFQAKCJYEJEW-UHFFFAOYSA-N ethyl 3-[8-[[4-methyl-5-[(3-methyl-4-oxophthalazin-1-yl)methyl]-1,2,4-triazol-3-yl]sulfanyl]octanoylamino]benzoate Chemical compound CCOC(=O)C1=CC(NC(=O)CCCCCCCSC2=NN=C(CC3=NN(C)C(=O)C4=CC=CC=C34)N2C)=CC=C1 GWNFQAKCJYEJEW-UHFFFAOYSA-N 0.000 claims description 2
- JAXFJECJQZDFJS-XHEPKHHKSA-N gtpl8555 Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@H](B1O[C@@]2(C)[C@H]3C[C@H](C3(C)C)C[C@H]2O1)CCC1=CC=C(F)C=C1 JAXFJECJQZDFJS-XHEPKHHKSA-N 0.000 claims description 2
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 claims description 2
- RENRQMCACQEWFC-UGKGYDQZSA-N lnp023 Chemical compound C1([C@H]2N(CC=3C=4C=CNC=4C(C)=CC=3OC)CC[C@@H](C2)OCC)=CC=C(C(O)=O)C=C1 RENRQMCACQEWFC-UGKGYDQZSA-N 0.000 claims description 2
- YGBMCLDVRUGXOV-UHFFFAOYSA-N n-[6-[6-chloro-5-[(4-fluorophenyl)sulfonylamino]pyridin-3-yl]-1,3-benzothiazol-2-yl]acetamide Chemical compound C1=C2SC(NC(=O)C)=NC2=CC=C1C(C=1)=CN=C(Cl)C=1NS(=O)(=O)C1=CC=C(F)C=C1 YGBMCLDVRUGXOV-UHFFFAOYSA-N 0.000 claims description 2
- LPOIGVZLNWEGJG-UHFFFAOYSA-N n-benzyl-5-(4-methylpiperazin-1-yl)-2-nitroaniline Chemical compound C1CN(C)CCN1C1=CC=C([N+]([O-])=O)C(NCC=2C=CC=CC=2)=C1 LPOIGVZLNWEGJG-UHFFFAOYSA-N 0.000 claims description 2
- IOMMMLWIABWRKL-WUTDNEBXSA-N nazartinib Chemical compound C1N(C(=O)/C=C/CN(C)C)CCCC[C@H]1N1C2=C(Cl)C=CC=C2N=C1NC(=O)C1=CC=NC(C)=C1 IOMMMLWIABWRKL-WUTDNEBXSA-N 0.000 claims description 2
- PIDFDZJZLOTZTM-KHVQSSSXSA-N ombitasvir Chemical compound COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)NC1=CC=C([C@H]2N([C@@H](CC2)C=2C=CC(NC(=O)[C@H]3N(CCC3)C(=O)[C@@H](NC(=O)OC)C(C)C)=CC=2)C=2C=CC(=CC=2)C(C)(C)C)C=C1 PIDFDZJZLOTZTM-KHVQSSSXSA-N 0.000 claims description 2
- 125000005561 phenanthryl group Chemical group 0.000 claims description 2
- 125000005580 triphenylene group Chemical group 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 125000003914 fluoranthenyl group Chemical group C1(=CC=C2C=CC=C3C4=CC=CC=C4C1=C23)* 0.000 claims 1
- ZBELDPMWYXDLNY-UHFFFAOYSA-N methyl 9-(4-bromo-2-fluoroanilino)-[1,3]thiazolo[5,4-f]quinazoline-2-carboximidate Chemical compound C12=C3SC(C(=N)OC)=NC3=CC=C2N=CN=C1NC1=CC=C(Br)C=C1F ZBELDPMWYXDLNY-UHFFFAOYSA-N 0.000 claims 1
- 239000010410 layer Substances 0.000 description 49
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 36
- 239000000203 mixture Substances 0.000 description 33
- 229910052739 hydrogen Inorganic materials 0.000 description 22
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 21
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 18
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 16
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical group CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 14
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 230000015572 biosynthetic process Effects 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 12
- 238000002347 injection Methods 0.000 description 12
- 239000007924 injection Substances 0.000 description 12
- 239000012044 organic layer Substances 0.000 description 12
- 229910052757 nitrogen Inorganic materials 0.000 description 11
- 238000003786 synthesis reaction Methods 0.000 description 11
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 10
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 9
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 238000004440 column chromatography Methods 0.000 description 8
- 239000012043 crude product Substances 0.000 description 8
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 8
- 229940078552 o-xylene Drugs 0.000 description 7
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 125000004076 pyridyl group Chemical group 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 239000011368 organic material Substances 0.000 description 5
- 229930192474 thiophene Natural products 0.000 description 5
- 125000003944 tolyl group Chemical group 0.000 description 5
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 238000000151 deposition Methods 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 4
- 150000002894 organic compounds Chemical class 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- UZVGSSNIUNSOFA-UHFFFAOYSA-N dibenzofuran-1-carboxylic acid Chemical compound O1C2=CC=CC=C2C2=C1C=CC=C2C(=O)O UZVGSSNIUNSOFA-UHFFFAOYSA-N 0.000 description 3
- DKHNGUNXLDCATP-UHFFFAOYSA-N dipyrazino[2,3-f:2',3'-h]quinoxaline-2,3,6,7,10,11-hexacarbonitrile Chemical group C12=NC(C#N)=C(C#N)N=C2C2=NC(C#N)=C(C#N)N=C2C2=C1N=C(C#N)C(C#N)=N2 DKHNGUNXLDCATP-UHFFFAOYSA-N 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- DKGYESBFCGKOJC-UHFFFAOYSA-N thiophen-3-amine Chemical compound NC=1C=CSC=1 DKGYESBFCGKOJC-UHFFFAOYSA-N 0.000 description 3
- 238000007740 vapor deposition Methods 0.000 description 3
- 125000005023 xylyl group Chemical group 0.000 description 3
- FARVZDDWFCEDRO-UHFFFAOYSA-N 14-(10-bromoanthracen-9-yl)-10,10,21,21-tetramethyl-14-azapentacyclo[11.8.0.03,11.04,9.015,20]henicosa-1(13),2,4,6,8,11,15,17,19-nonaene Chemical compound BrC1=C2C=CC=CC2=C(C2=CC=CC=C12)N1C=2C=C3C(=CC=2C(C=2C=CC=CC1=2)(C)C)C1=CC=CC=C1C3(C)C FARVZDDWFCEDRO-UHFFFAOYSA-N 0.000 description 2
- FYFDCHKPBDJDBS-UHFFFAOYSA-N 14-(5-bromonaphthalen-1-yl)-10,10,21,21-tetramethyl-14-azapentacyclo[11.8.0.03,11.04,9.015,20]henicosa-1(13),2,4,6,8,11,15,17,19-nonaene Chemical compound BrC1=C2C=CC=C(C2=CC=C1)N1C=2C=C3C(=CC=2C(C=2C=CC=CC1=2)(C)C)C1=CC=CC=C1C3(C)C FYFDCHKPBDJDBS-UHFFFAOYSA-N 0.000 description 2
- RHPVVNRNAHRJOQ-UHFFFAOYSA-N 4-methyl-n-(4-methylphenyl)aniline Chemical compound C1=CC(C)=CC=C1NC1=CC=C(C)C=C1 RHPVVNRNAHRJOQ-UHFFFAOYSA-N 0.000 description 2
- HOCDGTBWMKJCEF-UHFFFAOYSA-N CC1(C)C(C=C(C=C2)NC(C(C)=CC=C3)=C3C(O)=O)=C2C2=CC=CC=C12 Chemical compound CC1(C)C(C=C(C=C2)NC(C(C)=CC=C3)=C3C(O)=O)=C2C2=CC=CC=C12 HOCDGTBWMKJCEF-UHFFFAOYSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 2
- 229910000024 caesium carbonate Inorganic materials 0.000 description 2
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthene Chemical compound C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 2
- 238000004770 highest occupied molecular orbital Methods 0.000 description 2
- 230000005525 hole transport Effects 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- 238000004768 lowest unoccupied molecular orbital Methods 0.000 description 2
- NXPHGHWWQRMDIA-UHFFFAOYSA-M magnesium;carbanide;bromide Chemical compound [CH3-].[Mg+2].[Br-] NXPHGHWWQRMDIA-UHFFFAOYSA-M 0.000 description 2
- 229940098779 methanesulfonic acid Drugs 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000010453 quartz Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 238000010189 synthetic method Methods 0.000 description 2
- PQKIVTQXWLCNPV-UHFFFAOYSA-N 1,6-dibromo-9H-fluorene Chemical compound BrC1=CC=CC=2C3=CC(=CC=C3CC1=2)Br PQKIVTQXWLCNPV-UHFFFAOYSA-N 0.000 description 1
- OVAZRIRNHUWXFE-UHFFFAOYSA-N 10,10,21,21-tetramethyl-14-azapentacyclo[11.8.0.03,11.04,9.015,20]henicosa-1(13),2,4,6,8,11,15,17,19-nonaene Chemical compound C1=CC=C2C(C)(C)C(C=C3C4=CC=CC=C4C(C3=C3)(C)C)=C3NC2=C1 OVAZRIRNHUWXFE-UHFFFAOYSA-N 0.000 description 1
- MBHPOBSZPYEADG-UHFFFAOYSA-N 2-bromo-9,9-dimethylfluorene Chemical compound C1=C(Br)C=C2C(C)(C)C3=CC=CC=C3C2=C1 MBHPOBSZPYEADG-UHFFFAOYSA-N 0.000 description 1
- AEPHTQXPISWIAI-UHFFFAOYSA-N 2-naphthalen-1-yl-9-[4-[1-[4-(10-naphthalen-2-ylanthracen-9-yl)phenyl]benzimidazol-2-yl]phenyl]-1,10-phenanthroline Chemical compound C1(=CC=CC2=CC=CC=C12)C1=NC2=C3N=C(C=CC3=CC=C2C=C1)C1=CC=C(C=C1)C1=NC2=C(N1C1=CC=C(C=C1)C=1C3=CC=CC=C3C(=C3C=CC=CC=13)C1=CC3=CC=CC=C3C=C1)C=CC=C2 AEPHTQXPISWIAI-UHFFFAOYSA-N 0.000 description 1
- PJRFQXFIHQAWOH-UHFFFAOYSA-N 3,15-diphenylheptacyclo[15.7.1.15,9.02,16.04,14.021,25.013,26]hexacosa-1(24),2(16),3,5,7,9(26),10,12,14,17,19,21(25),22-tridecaene Chemical group C1=CC=CC=C1C([C]1C2=CC=CC3=CC=CC([C]23)=C11)=C(C=2C3=C4C=CC=C3C=CC=2)C4=C1C1=CC=CC=C1 PJRFQXFIHQAWOH-UHFFFAOYSA-N 0.000 description 1
- FDPBPKDNWCZVQR-UHFFFAOYSA-N 3-bromodibenzothiophene Chemical compound C1=CC=C2C3=CC=C(Br)C=C3SC2=C1 FDPBPKDNWCZVQR-UHFFFAOYSA-N 0.000 description 1
- RLPAWKJLZUFLCR-UHFFFAOYSA-N 4-(4-aminophenyl)-3-naphthalen-1-yl-n,n-diphenylaniline Chemical compound C1=CC(N)=CC=C1C1=CC=C(N(C=2C=CC=CC=2)C=2C=CC=CC=2)C=C1C1=CC=CC2=CC=CC=C12 RLPAWKJLZUFLCR-UHFFFAOYSA-N 0.000 description 1
- DQAZPZIYEOGZAF-UHFFFAOYSA-N 4-ethyl-n-[4-(3-ethynylanilino)-7-methoxyquinazolin-6-yl]piperazine-1-carboxamide Chemical compound C1CN(CC)CCN1C(=O)NC(C(=CC1=NC=N2)OC)=CC1=C2NC1=CC=CC(C#C)=C1 DQAZPZIYEOGZAF-UHFFFAOYSA-N 0.000 description 1
- BRUOAURMAFDGLP-UHFFFAOYSA-N 9,10-dibromoanthracene Chemical compound C1=CC=C2C(Br)=C(C=CC=C3)C3=C(Br)C2=C1 BRUOAURMAFDGLP-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- CLPOZMCJDQVJTD-UHFFFAOYSA-N BrC1=CC=CC2=C(C=CC=C12)Br.BrC1=CC=CC2=C(C=CC=C12)Br Chemical compound BrC1=CC=CC2=C(C=CC=C12)Br.BrC1=CC=CC2=C(C=CC=C12)Br CLPOZMCJDQVJTD-UHFFFAOYSA-N 0.000 description 1
- WYLIRYQDDKDHLT-UHFFFAOYSA-N CC1=CC=CC=C1C.CC1=CC=CC=C1C Chemical compound CC1=CC=CC=C1C.CC1=CC=CC=C1C WYLIRYQDDKDHLT-UHFFFAOYSA-N 0.000 description 1
- 229910018068 Li 2 O Inorganic materials 0.000 description 1
- BJHIFALGDNWZRM-UHFFFAOYSA-N N1C=CC=CC=C1.N1=CC=CC=C1 Chemical compound N1C=CC=CC=C1.N1=CC=CC=C1 BJHIFALGDNWZRM-UHFFFAOYSA-N 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 125000002676 chrysenyl group Chemical group C1(=CC=CC=2C3=CC=C4C=CC=CC4=C3C=CC12)* 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 239000002019 doping agent Substances 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000001194 electroluminescence spectrum Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000005281 excited state Effects 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- AMGQUBHHOARCQH-UHFFFAOYSA-N indium;oxotin Chemical compound [In].[Sn]=O AMGQUBHHOARCQH-UHFFFAOYSA-N 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910001507 metal halide Inorganic materials 0.000 description 1
- 150000005309 metal halides Chemical class 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000002080 perylenyl group Chemical group C1(=CC=C2C=CC=C3C4=CC=CC5=CC=CC(C1=C23)=C45)* 0.000 description 1
- 125000001792 phenanthrenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C=CC12)* 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 125000001725 pyrenyl group Chemical group 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
- 238000002207 thermal evaporation Methods 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 125000003960 triphenylenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C3=CC=CC=C3C12)* 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/18—Ring systems of four or more rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/46—Phenazines
- C07D241/48—Phenazines with hydrocarbon radicals, substituted by nitrogen atoms, directly attached to the ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/38—[b, e]-condensed with two six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/18—[b, e]-condensed with two six-membered rings
- C07D279/22—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D293/00—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms
- C07D293/10—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D421/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms
- C07D421/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms containing two hetero rings
- C07D421/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/06—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/06—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/06—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D517/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms
- C07D517/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms in which the condensed system contains two hetero rings
- C07D517/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
- C07F7/0816—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring comprising Si as a ring atom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/11—OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/11—OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
- H10K50/12—OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers comprising dopants
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/40—Organosilicon compounds, e.g. TIPS pentacene
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/615—Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/615—Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
- H10K85/622—Polycyclic condensed aromatic hydrocarbons, e.g. anthracene containing four rings, e.g. pyrene
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/615—Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
- H10K85/623—Polycyclic condensed aromatic hydrocarbons, e.g. anthracene containing five rings, e.g. pentacene
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/615—Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
- H10K85/624—Polycyclic condensed aromatic hydrocarbons, e.g. anthracene containing six or more rings
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/631—Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/631—Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine
- H10K85/633—Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine comprising polycyclic condensed aromatic hydrocarbons as substituents on the nitrogen atom
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/631—Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine
- H10K85/636—Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine comprising heteroaromatic hydrocarbons as substituents on the nitrogen atom
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/654—Aromatic compounds comprising a hetero atom comprising only nitrogen as heteroatom
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/657—Polycyclic condensed heteroaromatic hydrocarbons
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/657—Polycyclic condensed heteroaromatic hydrocarbons
- H10K85/6572—Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/657—Polycyclic condensed heteroaromatic hydrocarbons
- H10K85/6574—Polycyclic condensed heteroaromatic hydrocarbons comprising only oxygen in the heteroaromatic polycondensed ring system, e.g. cumarine dyes
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/657—Polycyclic condensed heteroaromatic hydrocarbons
- H10K85/6576—Polycyclic condensed heteroaromatic hydrocarbons comprising only sulfur in the heteroaromatic polycondensed ring system, e.g. benzothiophene
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1011—Condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
- C09K2211/1033—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom with oxygen
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
- C09K2211/1037—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom with sulfur
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
- C09K2211/104—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom with other heteroatoms
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1044—Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1059—Heterocyclic compounds characterised by ligands containing three nitrogen atoms as heteroatoms
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1088—Heterocyclic compounds characterised by ligands containing oxygen as the only heteroatom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1092—Heterocyclic compounds characterised by ligands containing sulfur as the only heteroatom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1096—Heterocyclic compounds characterised by ligands containing other heteroatoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Physics & Mathematics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Optics & Photonics (AREA)
- Electroluminescent Light Sources (AREA)
Abstract
本發明提供一種雜芳族化合物及使用該雜芳族化合物作為有機電激發光元件發光層的螢光客體材料。該有機電激發光元件可以降低驅動電壓,或運作出較高的電流效率,或較長的半衰期。
Description
本發明是關於一種銥複合物,特別是關於使用該銥複合物的有機電激發光(下文稱為有機EL)元件。
有機電激發光(有機EL)元件是一種有機發光二極體(OLED),其中發光層是由有機化合物製成的膜,有機化合物可回應電流而發光。包含有機化合物的發光層被夾置於兩個電極之間。有機EL組件由於其高照度、重量輕、超薄外形、自照明而無需背光、低功耗、廣視角、高對比、製造方法簡單以及反應時間快速而被應用於平板顯示器。
典型上,有機EL是由位於兩個電極之間的有機材料層構成。有機材料層包括電洞傳輸層(hole transporting layer,HTL)、發光層(emitting layer,EML)、及電子傳輸層(electron transporting layer,ETL)。有機電激發光的基本原理涉及載子(carrier)的注入、傳輸、及複合以及激子(exciton)的形成,以進行發光。當向有機EL元件施加外部電壓時,電子和電洞分別從陰極和陽極注入。電子從陰極注入最低未佔用分子軌域(lowest unoccupied molecular orbital,LUMO) 中,而電洞從陽極注入最高佔用分子軌域(highest occupied molecular orbital,HOMO)中。隨後,電子在發光層中與電洞重組而形成激子,然後激子失活而發光。當發光分子吸收能量而達到激發態時,依據電子和電洞的自旋組合,激子可呈單重態或三重態。眾所周知,在電激發下形成的激子通常包括25%的單重態激子和75%的三重態激子。然而,在螢光材料中,75%的三重態激子中的電生成能量將作為熱量消散,因為從三重態衰減是自旋禁阻(spin forbidden)的。因此,螢光電激發光元件僅具有25%的內部量子效率(internal quantum efficiency),導致理論上最高的外部量子效率(EQE)僅有5%,因為元件的光輸出耦合效率只有約20%。相較於螢光電激發光元件,磷光有機EL元件利用自旋─軌域相互作用(spin-orbit interacttion)來促進單重態與三重態之間的系統間穿越(intersystem crossing),因此來自單重態和三重態的發光皆可取得,而且電激發光元件的內部量子效率可自25%升至100%。
對於使用有機EL元件的平板顯示器來說,有機EL元件中使用的有機材料仍無法令人滿意。如果可以在降低驅動電壓、或提高電流效率、或延長半衰期等等任何一方面,能有改善,都足以使有機EL元件或平板顯示器等相關產業有明顯的發展與提升。因此,本發明的目的之一,是提供一種有機化合物,可以降低有機EL元件的驅動電壓、或提高其電流效率、或延長其半衰期。
因此,本發明的目的是提供一種新的雜芳族化合物,可以作為有機EL元件發光層的螢光客體材料,能夠降低有機EL元件的驅動電壓、或提高其電流效率、或延長其半衰期,或改善功耗。
本發明的另一目的是提供一種雜芳族化合物,或使用該雜芳族化合物的有機電激發光元件,其可以較低的驅動電壓運作,或者操作出較高的電流效率,或較長的半衰期。
依據本發明,提供了一種可用於有機EL元件的雜芳族化合物。其中,發光顏色為藍色的有機電激發光元件,可以是優選。該雜芳族化合物可由下式(1)表示:式(1), X1
可以是二價橋並選自於由O、S、Se、CR4
R5
、NR6
和 SiR7
R8
組成的群組。X2
可以是不存在,也可以是二價橋並選自於由O、S、Se、CR9
R10
、NR11
和 SiR12
R13
組成的群組;其中X2
不存在可以是優選。A可以表示具有2、3、4、5、6、7、8或9個環(2至9個環)的經取代或未經取代的稠合環烴單元。m可為0、1、2、3或4(0至4)的整數。B可表示以下式(2):式(2), 其中環C可以表示苯環,也可以表示具有2、3、4或5個環的的經取代或未經取代的稠合環烴單元。Y可以表示二價橋並選自於由O、S、Se、CR14
R15
、NR16
和SiR17
R18
所組成的群組,其中S或CR14
R15
可以是優選,且其中R14
和R15
可以是各自獨立的以甲基為優選。 R3
至R18
可獨立為氫原子、鹵素、具有1至60個碳原子的經取代或未經取代烷基、具有6至60個碳原子的經取代或未經取代芳基、具有6至60個碳原子的經取代或未經取代芳烷基、具有3至60個碳原子的經取代或未經取代雜芳基、及具有6至60個碳原子的經取代或未經取代芳胺基。 其中可以理解的是,本發明所述的“X2
不存在”,是指式(1)結構的下面為開環,如下式(1’)所示:式(1’) 當X2
不存在的時候, R1
和R2
獨立為氫原子、鹵素、具有1至60個碳原子的經取代或未經取代烷基、具有6至60個碳原子的經取代或未經取代芳基、具有6至60個碳原子的經取代或未經取代芳烷基、具有3至60個碳原子的經取代或未經取代雜芳基、或具有6至60個碳原子的經取代或未經取代芳胺基;或者兩個或兩個以上的R1
可以選擇彼此連接,並可以與共同連接的苯環共同定義出至少一環烴;或者兩個或兩個以上的R2
可以選擇彼此連接,並可以與共同連接的苯環共同定義出至少一環烴。 式(1)右下方的苯環與(R2
)m
,以及式(1)左下方的苯環與(R1
)m
,最好都不要共同構成下列結構:式(1)右下方的苯環與(R2
)m
,以及式(1)左下方的苯環與(R1
)m
,都不共同構成上述結構的時候,將該雜芳族化合物,用於作為有機EL元件的發光層或有機薄膜層,可顯示出良好的特性。例如,但不限於,將該雜芳族化合物,用於作為發光層的客體材料,可以使元件發光顏色為藍色的元件驅動電壓,大幅降低,低至約3.0~3.5 V。與構成上述結構的雜芳族化合物相比,本發明元件驅動電壓降幅可以達到約14%,最多可以達到約23%。當X2不存在的時候,該雜芳族化合物可使電流效率約為6.0~6.9 cd/A,也就是至少有約6.0 cd/A,最高可以達到約6.9 cd/A。另外,當X2不存在的時候,該雜芳族化合物可使組件半衰期長達約235~450小時,也就是至少有約235小時,最長可以到達約450小時。
本發明進一步提供了一種有機電激發光元件。該有機電激發光元件包含由陰極和陽極組成的一電極對、及在該電極對之間的一發光層及一個或更多個有機薄膜層。該發光層和該有機薄膜層中之至少一者包含式(1)的雜芳族化合物。
本發明欲探究前述有機材料以及使用此類有機材料的有機EL裝置。在下文中將提供生產、結構以及要素的詳細描述以使本發明可充分地被理解。顯然本發明的應用並不限於本領域所屬技術領域技術人員所熟悉的特定細節。另一方面,普遍周知的常見元素和過程並未詳細描述于本發明中,且不應對本發明產生不必要的限制。現將在下文中更詳細地描述本發明的一些較佳實施方式。然而,應當理解的是,除了本文明確描述的實施例之外,本發明還可實施於各種其他實施例中,也就是說,本發明還可廣泛應用於其他實施例,且本發明的範圍不會因此受到明確的限制,只受隨附申請專利範圍的內容限制。
在本發明的一個實施例中,涉及一種雜芳族化合物,其可作為有機電激發光元件的螢光發光客體材料。其中,發光顏色為藍色的有機電激發光元件,可以是優選。該雜芳族化合物可由下式(1)表示:
式(1)。 X1
可以是二價橋並選自於由O、S、Se、CR4
R5
、NR6
和 SiR7
R8
組成的群組。X2
可以是不存在,也可以是二價橋並選自於由O、S、Se、CR9
R10
、NR11
和 SiR12
R13
組成的群組;其中X2
不存在可以是優選。A可以表示具有2、3、4、5、6、7、8或9個環(2至9個環)的經取代或未經取代的稠合環烴單元。m可為0、1、2、3或4(0至4)的整數。B可表示以下式(2):式(2), 其中環C可以表示苯環,也可以表示具有2、3、4或5個(2至5個)環的經取代或未經取代的稠合環烴單元。Y可以表示二價橋並選自於由O、S、Se、CR14
R15
、NR16
和SiR17
R18
所組成的群組,其中S為CR14
R15
可以是優選,且其中R14
和R15
可以是各自獨立的以甲基為優選。 R3
至R18
可各自獨立為氫原子、鹵素、具有1至60個碳原子的經取代或未經取代烷基(優選具有1至20個碳原子的經取代或未經取代烷基;更優選具有1至10個碳原子的經取代或未經取代烷基;最優選具有1至5個碳原子的經取代或未經取代烷基)、具有6至60個碳原子的經取代或未經取代芳基、具有6至60個碳原子的經取代或未經取代芳烷基、具有3至60個碳原子的經取代或未經取代雜芳基、及具有6至60個碳原子的經取代或未經取代芳胺基。 其中可以理解的是,本發明所述的“X2
不存在”,是指式(1)結構的下面為開環,如下式(1’)所示:式(1’) 當X2
不存在的時候, R1
和R2
獨立為氫原子、鹵素、具有1至60個碳原子的經取代或未經取代烷基(優選具有1至20個碳原子的經取代或未經取代烷基;更優選具有1至10個碳原子的經取代或未經取代烷基;最優選具有1至5個碳原子的經取代或未經取代烷基)、具有6至60個碳原子的經取代或未經取代芳基、具有6至60個碳原子的經取代或未經取代芳烷基、具有3至60個碳原子的經取代或未經取代雜芳基、或具有6至60個碳原子的經取代或未經取代芳胺基;或者兩個或兩個以上的R1
可以選擇彼此連接,並可以與共同連接的苯環共同定義出至少一環烴;或者兩個或兩個以上的R2
可以選擇彼此連接,並可以與共同連接的苯環共同定義出至少一環烴。 式(1)右下方的苯環與(R2
)m
,以及式(1)左下方的苯環與(R1
)m
,最好都不要共同構成下列結構:式(1)右下方的苯環與(R2
)m
,以及式(1)左下方的苯環與(R1
)m
,都不共同構成上述結構的時候,將該雜芳族化合物,用於作為有機EL元件的發光層或有機薄膜層,可顯示出良好的特性。例如,但不限於,將該雜芳族化合物,用於作為發光層的客體材料,可以使元件發光顏色為藍色的元件驅動電壓,大幅降低,低至約3.0~3.5 V。與構成上述結構的雜芳族化合物相比,本發明元件驅動電壓降幅可以達到約14%,最多可以達到約23%。 當X2
不存在的時候,該雜芳族化合物可使電流效率約為6.0~6.9 cd/A,也就是至少有約6.0 cd/A,最高可以達到約6.9 cd/A。另外,當X2
不存在的時候,該雜芳族化合物可使組件半衰期長達約235~450小時,也就是至少有約235小時,最長可以到達約450小時。 R1
最好是異於B。R2
也最好是異於B。 兩個或兩個以上的R2
可以選擇彼此連接,並可以與共同連接的苯環共同定義出至少一環烴。該至少一環烴與該苯環可以稠合 (fused with)或共同構成例如,但不限於萘基、二苯並呋喃基、或二苯並噻吩基(優選可以是萘基)。 兩個或兩個以上的R1
可以彼此連接,並可以與共同連接的苯環共同定義出至少一環烴。該至少一環烴與該苯環可以稠合(fused with)或共同構成例如,但不限於萘基、二苯並呋喃基、或二苯並噻吩基(優選可以是萘基)。 當X2
不存在的時候, R1
和R2
可以是獨立為氫原子、鹵素、具有1至60個碳原子(優選1至20個碳原子;更優選1至10個碳原子;最優選1至5個碳原子,例如是甲基)的經取代或未經取代烷基、具有6至60個碳原子的經取代或未經取代芳基(優選可以是苯基)、具有6至60個碳原子的經取代或未經取代芳烷基、具有3至60個碳原子的經取代或未經取代雜芳基、及具有6至60個碳原子的經取代或未經取代芳胺基。 當X2
是二價橋並選自於由O、S、Se、CR9
R10
、NR11
和 SiR12
R13
組成的群組的時候,其中可以O或SiR12
R13
可以是優選的,R1
和R2
可以獨立為氫原子、鹵素、具有1至60個碳原子(優選1至20個碳原子;更優選1至10個碳原子;最優選1至5個碳原子)的經取代或未經取代烷基、具有6至60個碳原子的經取代或未經取代芳基、具有6至60個碳原子的經取代或未經取代芳烷基、具有3至60個碳原子的經取代或未經取代雜芳基、及具有6至60個碳原子的經取代或未經取代芳胺基。
在一些實施方式,A可表示經取代或未經取代的萘基(naphthyl group)、經取代或未經取代的菲基(phenanthrenyl group)、經取代或未經取代的蒽基(anthracenyl group)、經取代或未經取代的芘基(pyrenyl group)、經取代或未經取代的䓛基(chrysenyl group)、經取代或未經取代的三亞苯基(triphenylenyl group)、經取代或未經取代的苝基(perylenyl group)、經取代或未經取代的聯四苯基(tetraphenylenyl group)、經取代或未經取代的7,14-二苯基苊[1,2-k]熒蒽基(7,14-diphenylacenaphtho[1,2-k]fluoranthene group)。
在一些實施方式中,A可以是以下化學式中的一種結構: , 其中,R19
至R24
可獨立為氫原子、具有1至30個碳原子(優選1至20個碳原子;更優選1至10個碳原子;最優選1至5個碳原子)的經取代或未經取代烷基、具有6至30個碳原子的經取代或未經取代芳基、具有6至30個碳原子的經取代或未經取代芳烷基、具有3至30個碳原子的經取代或未經取代雜芳基、及具有6至30個碳原子的經取代或未經取代芳胺基。所述的經取代的萘基,其取代基可以是兩個甲基、兩個2-甲基噻吩基、或兩個異丙基。再者,R19
至R24
可以分別獨立為甲基、苯基、甲苯基、二甲苯基、吡啶基、噻吩基、異丙基、2-甲基噻吩基、異丁基或下列化學式中的一種結構:,,,,。
在一些實施方式,該雜芳族化合物可以由以下式(3)至式(15)中的一個表示: 式(3), 式(4),式(5),式(6), 式(7), 式(8), 式(9), 式(10), 式(11), 式(12),式(13),其中,X1
可以是二價橋並選自於由O、S、Se、CR4
R5
、NR6
和 SiR7
R8
組成的群組。X2
可以是不存在,也可以是二價橋並選自於由O、S、Se、CR9
R10
、NR11
和 SiR12
R13
組成的群組;其中X2
不存在可以是優選。 R4
、R5
、R6
、R7
、R8
、R9
、R10
、R12
、及R13
可以獨立為氫原子、鹵素、具有1至60個碳原子(優選1至20個碳原子;更優選1至10個碳原子;最優選1至5個碳原子)的經取代或未經取代烷基、具有6至60個碳原子的經取代或未經取代芳基、具有6至60個碳原子的經取代或未經取代芳烷基、具有3至60個碳原子的經取代或未經取代雜芳基、及具有6至60個碳原子的經取代或未經取代芳胺基。其中,R4
至R8
、R9
至R13
可以獨立為甲基、正丁基、苯基、甲苯基、吡啶基、或下列化學式中的一種結構:,,,。 R6
和R11
可以獨立為甲基、異丙基、正丁基、苯基、甲苯基、二甲苯基、吡啶基、或下列化學式中的一種結構:,,,,,,。 對於式(1),B可表示以下式(2):式(2), 其中環C可以表示苯環,也可以表示具有2、3、4或5個環的的經取代或未經取代的稠合環烴單元(例如稠合芳環單元)。該稠合芳環單元(環C),可以是萘基、菲基、蒽基、芘基、䓛基、三亞苯基、聯四苯基、或苝基。 A可以表示具有2、3、4、5、6、7、8或9個環的經取代或未經取代的稠合環烴單元。m可為0、1、2、3或4的整數。 Y可以表示二價橋並選自於由O、S、Se、CR14
R15
、NR16
和SiR17
R18
所組成的群組。R14
至R18
可獨立為氫原子、鹵素、具有1至60個碳原子(優選1至20個碳原子;更優選1至10個碳原子;最優選1至5個碳原子)的經取代或未經取代烷基、具有6至60個碳原子的經取代或未經取代芳基、具有6至60個碳原子的經取代或未經取代芳烷基、具有3至60個碳原子的經取代或未經取代雜芳基、及具有6至60個碳原子的經取代或未經取代芳胺基。其中,R8
、R9
、R11
、R12
可以獨立為甲基、乙基、正丙基、苯基、甲苯基、吡啶基、或正丁基。R10
可以是苯基、異丙基、二甲苯基、吡啶基、甲基、正丁基、甲苯基、或下列化學式中的一種結構:,。 對於式(1),R3
可以是氫原子、鹵素、具有1至60個碳原子的經取代或未經取代烷基、具有6至60個碳原子的經取代或未經取代芳基、具有6至60個碳原子的經取代或未經取代芳烷基、具有3至60個碳原子的經取代或未經取代雜芳基、及具有6至60個碳原子的經取代或未經取代芳胺基。R3
也可以是苯基、甲基、異丙苯基、吡啶基、異丁苯基、2-甲基噻吩基、或下列化學式中的一種結構:,。
較佳地,但不受限的,是該雜芳族化合物可以為以下化合物中之一:化合物1 化合物2 化合物3 化合物4化合物5 化合物6 化合物7 化合物8化合物9 化合物10 化合物11 化合物12化合物13 化合物14 化合物15 化合物16化合物17 化合物18 化合物19 化合物20化合物21 化合物22 化合物23 化合物24化合物25 化合物26 化合物27 化合物28化合物29 化合物30 化合物31 化合物32化合物33 化合物34 化合物35 化合物36化合物37 化合物38 化合物39 化合物40化合物41 化合物42 化合物43 化合物44化合物45 化合物46 化合物47 化合物48化合物49 化合物50 化合物51 化合物52化合物53 化合物54 化合物55 化合物56化合物57 化合物58 化合物59 化合物60化合物61 化合物62 化合物63 化合物64化合物65 化合物66 化合物67 化合物68化合物69 化合物70 化合物71 化合物72化合物73 化合物74 化合物75 化合物76化合物77 化合物78 化合物79 化合物80化合物81 化合物82 化合物83 化合物84化合物85 化合物86 化合物87 化合物88化合物89 化合物90 化合物91 化合物92化合物93 化合物94 化合物95 化合物96化合物97 化合物98 化合物99 化合物100化合物101 化合物102 化合物103 化合物104化合物105 化合物106 化合物107 化合物108化合物109 化合物110 化合物111 化合物112化合物113 化合物114 化合物115 化合物116化合物117 化合物118 化合物119 化合物120化合物121 化合物122 化合物123 化合物124化合物125 化合物126 化合物127 化合物128化合物129 化合物130 化合物131 化合物132化合物133 化合物134 化合物135 化合物136化合物137 化合物138 化合物139 化合物140化合物141 化合物142 化合物143 化合物144化合物145 化合物146 化合物147 化合物148化合物149 化合物150 化合物151 化合物152化合物153 化合物154 化合物155 化合物156化合物157 化合物158 化合物159 化合物160化合物161 化合物162 化合物163 化合物164化合物165 化合物166 化合物167 化合物168化合物169 化合物170 化合物171 化合物172化合物173 化合物174 化合物175 化合物176化合物177 化合物178 化合物179 化合物180化合物181 化合物182 化合物1783 化合物184化合物185 化合物186 化合物187 化合物188化合物189 化合物190 化合物191 化合物192化合物193 化合物194 化合物195 化合物196化合物197 化合物198 化合物199 化合物200化合物201 化合物202 化合物203 化合物204化合物205 化合物206 化合物207 化合物208化合物209 化合物210 化合物211 化合物212化合物213 化合物214 化合物215 化合物216化合物217 化合物218 化合物219 化合物220化合物221 化合物222 化合物223 化合物224化合物225 化合物226 化合物227 化合物228化合物229 化合物230 化合物231 化合物232化合物233 化合物234 化合物235 化合物236化合物237 化合物238 化合物239 化合物240化合物241 化合物242 化合物243 化合物244化合物245 化合物246 化合物247 化合物248化合物249 化合物250 化合物251 化合物252化合物253 化合物254 化合物255 化合物256化合物257 化合物258 化合物259 化合物260化合物261 化合物262 化合物263 化合物264化合物265 化合物266 化合物267 化合物268化合物269 化合物270 化合物271 化合物272化合物273 化合物274 化合物275 化合物276化合物277 化合物278 化合物279 化合物280化合物281 化合物282 化合物283 化合物284化合物285 化合物286 化合物287 化合物288化合物289 化合物290 化合物291 化合物292化合物293 化合物294 化合物295 化合物296化合物297 化合物298 化合物299 化合物300化合物301 化合物302 化合物303 化合物304化合物305 化合物306 化合物307 化合物308化合物309 化合物310 化合物311 化合物312化合物313 化合物314 化合物315化合物316 化合物317 化合物318化合物319 化合物320 化合物321化合物322 化合物323 化合物324化合物325 化合物326 化合物327化合物328 化合物329 化合物330化合物331 化合物332 化合物333化合物334 化合物335 化合物336化合物337 化合物338 化合物339化合物340 化合物341 化合物342 化合物343化合物344 化合物345 化合物346 化合物347化合物348 化合物349 化合物350 化合物351化合物352 化合物353 化合物354 化合物355化合物356 化合物357,及 化合物358。
在本發明的另一個實施方式中,提供了一種有機電激發光元件,其發光顏色優選可以是藍色。該有機電激發光元件包含由陰極和陽極組成的電極對、及在該電極對之間的發光層及一個或多個有機薄膜層。該發光層和有機薄膜層中的至少一個包含式(1)的雜芳族化合物。
在一些實施方式中,發光層所包含的雜芳族化合物可以是螢光客體材料。特別的,這樣的發光層可以發出藍色的螢光,且其元件驅動電壓可以被降低。
在本發明的另一實施方式中,該有機電激發光組件為一發光面板。在本發明的其他實施方式中,該有機電激發光組件為背光面板。
以下將通過實施例來清楚闡明本發明的雜芳族化合物的細節製備。然而,本發明並不限於這些實施例。實施例1至實施例18只是舉例說明本發明的雜芳族化合物的製備,而實施例19也僅只是舉例說明若干有機EL元件的製造及測試報告而已,並非用以限制本發明。 實施例1
甲基2-((9,9-二甲基-9H-芴-2-基)胺基)苯甲酸(methyl 2-((9,9-dimethyl-9H-fluoren-2-yl)amino)-benzoate)的合成
將10 g (36.6 mmol)的2-溴-9,9-二甲基-9H-芴、6.64 g (43.9 mmol)的甲基2-鄰氨基苯甲酸、0.3 g (1.46 mmol)的乙酸鈀(Pd(OAc)2
)、17.9 g (54.9 mmol)的碳酸銫(CS2
CO3
)、及120 ml 的鄰二甲苯(o-xylene),五者脫氣並置於氮氣下,然後加熱回流12小時。在反應完成後,可以讓混合物冷卻至室溫。隨後,減壓以將溶劑從有機層移除,用柱層析純化粗產物,得到10 g的黃色油狀甲基2-((9,9-二甲基-9H-芴-2-基)胺基)苯甲酸(79.6 %)。1
H NMR (CDCl3
,400 MHz):化學位移(ppm) 8.97(s, 1H), 8.11(d, 1H), 7.87(d, 1H), 7.75-7.64(m, 3H), 7.41-7.29(m, 3H), 7.08(m, 1H), 6.92(d, 1H), 6.77(d, 1H), 3.79(s, 3H), 1.57(s, 3H) , 1.54(s, 3H)。
2-(2-((9,9-二甲基-9H-芴-2-基)胺基)苯基)-丙烷-2-醇(2-(2-((9,9-dimethyl-9H-fluoren-2-yl)amino)phenyl)- propan-2-ol)的合成
將甲基2-((9,9-二甲基-9H-芴-2-基)胺基)苯甲酸(10 g,29.1 mmol)的化合物,與100 ml的四氫呋喃(THF)混合。對此,在室溫下,慢慢加入59 ml,3M的甲基溴化鎂(CH3
MgBr),得到混合物。接著在室溫下攪拌混合物3小時。在反應完成後,加入氯化銨溶液,得到反應混合物。然後,用乙酸乙酯/水進行萃取,分離出有機層。減壓以將溶劑從有機層移除,用柱層析純化粗產物,得到9 g的黃色油狀2-(2-((9,9-二甲基-9H-芴-2-基)胺基)苯基)-丙烷-2-醇(90 %)。1
H NMR (CDCl3
,400 MHz):化學位移(ppm) 8.91(s, 1H),7.81(d, 1H), 7.59(d, 1H), 7.54(d, 1H), 7.35-7.39(m, 3H), 7.29(m, 1H), 6.92(m, 1H), 6.76-6.74(d, 2H), 6.58(d, 1H), 3.88(s, 1H), 1.53(s, 3H) , 1.51(s, 3H) , 1.35(s, 6H)。
7,7,13,13-四甲基-7,13-二氫-5H-茚並-[1,2-b]-吖啶(7,7,13,13-tetramethyl-7,13-dihydro-5H-indeno-[1,2-b]-acridine)的合成
將化合物2-(2-((9,9-二甲基-9H-芴-2-基)胺基)苯基)-丙-2-醇(2-(2-((9,9-dimethyl-9H-fluoren-2-yl)amino)phenyl)-propan-2-ol) 27 g (78.6 mmol)與400 ml的二氯甲烷(CH2
Cl2
)混合。對此,在室溫下,慢慢加入51 ml的甲基磺酸(CH3
SO3
H)和37 ml的磷酸(H3
PO4
),得到混合物。接著在室溫下攪拌混合物12小時。反應完成後,加入冰水(ice-cold water),得到反應混合物。隨後,將20 %氫氧化鈉溶液加入混合物,然後用乙酸乙酯/水進行萃取,分離出有機層。減壓將溶劑從有機層移除。用柱層析純化粗產物,得到15 g的黃色固體狀7,7,13,13-四甲基-7,13-二氫-5H-茚並-[1,2-b] 吖啶(58.8%)。1
H NMR (CDCl3
,400 MHz):化學位移(ppm) 8.95(s, 1H),7.79(s, 1H), 7.72(d, 1H), 7.43(d, 1H), 7.36(d, 1H), 7.25(m, 1H), 7.16(dd, 1H), 7.04(m, 1H), 6.87(s, 1H),6.81-6.78(m, 2H) 1.55(s, 6H), 1.38(s, 6H)。
5-(10-溴蒽-9-基)- 7,7,13,13-四甲基-7,13-二氫-5H-茚並-[1,2-b]吖啶的合成
將2.9g(8.9mmol)的7,7,13,13-四甲基-7,13-二氫-5H-茚並-[1,2-b]吖啶(7,7,13,13-tetramethyl-7,13- dihydro-5H-indeno-[1,2-b]acridine)、3g(8.9mmol)的9,10-二溴蒽、0.08g (0.36mmol)的乙酸鈀(Pd(OAc)2
)、2.56g (26.7mmol)的叔丁醇鈉(NaOtBu;sodium tert-butoxide)、及50ml的鄰二甲苯(o-Xylene),五者的混合物脫氣並置於氮氣下,然後在140℃加熱12小時。反應完成後,使混合物冷卻至室溫。隨後,將150 ml的甲醇加到混合物中,得到的沉澱物經過濾並用甲醇洗滌,得到黃色固體。產率:21.23g,23%。1
H NMR (CDCl3
, 400 MHz):化學位移(ppm) 8.11 (d, 2H), 7.91(d, 2H),7.83(d, H), 7.54 (d, 2H), 7.45-7.41(m, 5H), 7.35(m, H), 7.25 (m, H), 7.05-7.02(m, 2H), 6.79(m, H),6.69(d, H) ,6.58(d, H), 1.56(s, 6H), 1.39(s, 6H)。
10-(7,7,13,13-四甲基-7,13-二氫-5H-茚並-[1,2-b]吖啶-5-基)蒽-9-胺 (化合物3)的合成
將1.2 g (2.07 mmol) 5-(10-溴蒽-9-基)- 7,7,13,13-四甲基-7,13-二氫-5H-茚並-[1,2-b]吖啶、0.45g (2.27 mmol)雙-對-甲苯基胺、0.004 g (0.02 mmol)的乙酸鈀(Pd(OAc)2
)、0.3 g (3.1 mmol)的叔丁醇鈉(NaOtBu)、及20 ml的鄰二甲苯(o-Xylene)的混合物脫氣並置於氮氣下,然後在140℃加熱12小時。反應完成後,使混合物冷卻至室溫。隨後,將60 ml的甲醇加到混合物中,得到的沉澱物經過濾並用甲醇洗滌,得到黃色固體。產率:0.68 g,47 %。1
H NMR (CDCl3
, 400 MHz):化學位移(ppm) 8.13(d, 2H),7.92(d, 2H), 7.85(d, H), 7.52(d, H), 7.47-7.42(m, 5H), 7.36(m, H) , 7.27(m, H), 7.07-7.03(m, 4H), 6.79(m, H),6.71(m, 3H) ,6.59-6.54(m, 5H), 2.35(s, 6H), 1.57(s, 6H), 1.38(s, 6H)。MS(m/z ,EI+
): 696.7。 實施例2
5-(5-溴萘-1-基)- 7,7,13,13-四甲基-7,13-二氫-5H-茚並[1,2-b]吖啶的合成
3.41 g (10.5 mmol) 7,7,13,13-四甲基-7,13-二氫-5H-茚並[1,2-b]吖啶(7,7,13,13-tetramethyl-7,13- dihydro-5H-indeno-[1,2-b]acridine), 3 g (10.5 mmol) 1,5-二溴萘(1,5-dibromonaphthalene), 0.02 g (0.1 mmol) Pd(OAc)2
, 1.51 g (15.8 mmol)叔丁醇鈉(sodium tert-butoxide), 和50 ml鄰二甲苯的混合物脫氣並置於氮氣下,然後在140℃加熱12小時。反應完成後,使混合物冷卻至室溫。隨後,將150 ml的甲醇加到混合物中,得到的沉澱物經過濾並用甲醇洗滌。用柱層析純化粗產物,得到黃色固體。產率:1.5 g, 27 %。1
H NMR (CDCl3
, 400 MHz):化學位移(ppm) 8.09(d, 2H),7.93(d, H), 7.84(d, H), 7.55(d, 2H), 7.45-7.41(m, 2H), 7.37(m, H) , 7.26(m, H), 7.07-7.03(m, 3H), 6.76(m, H),6.69(s, H) ,6.56(d, H), 1.56(s, 6H), 1.39(s, 6H)。
5-(7,7,13,13-四甲基-7,13-二氫-5H-茚並-[1,2-b]吖啶-5-基)-N,N-雙-對-甲苯萘-1-胺 (化合物2)的合成
1.5 g (2.83 mmol)的5-(5-溴萘-1-基)-7,7,13,13-四甲基-7,13-二氫-5H-茚並-[1,2-b]吖啶、0.61 g (3.11 mmol)的雙-對-甲苯基胺、0.006 g (0.02 mmol)的乙酸鈀(Pd(OAc)2
)、0.41 g (4.2 mmol) 的叔丁醇鈉(NaOtBu)、及30 ml的鄰二甲苯(o-Xylene),五者的混合物脫氣並置於氮氣下,然後在140℃加熱12小時。反應完成後,使混合物冷卻至室溫。隨後,將60 ml的甲醇加到混合物中,得到的沉澱物經過濾並用甲醇洗滌,得到黃色固體。產率:0.95 g, 52 %.1
H NMR (CDCl3
, 400 MHz):化學位移(ppm)8.01(d, H),7.75-7.71(m, 3H), 7.64(s, H), 7.45(m, 2H), 7.37(m, H), 7.17-7.11(m, 2H) , 7.04-6.97(m, 6H), 6.83(m, 2H), 6.75(s, H),6.68(d, H) ,6.59-6.54(m, 4H), 2.37(s, 6H), 1.55(s, 6H), 1.37(s, 6H). MS(m/z, EI+
): 646.6。 實施例3-9
我們已使用相同的合成方法得到一系列中間體。所以,以下的化合物(產物),都可以類似地合成而得。
實施例10
甲基2-(二苯並[b,d]噻吩-3-基胺)苯甲酸的合成
將5 g (19 mmol)的3-溴二苯並[b,d]噻吩、3.45 g (22.8 mmol) 的甲基2-鄰氨基苯甲酸、0.17 g (0.76 mmol) 的乙酸鈀(Pd(OAc)2
)、9.28 g (28.5 mmol) 的碳酸銫(CS2
CO3
)、及60 ml 的鄰二甲苯(o-xylene),五者的混合物脫氣並置於氮氣下,然後加熱回流12小時。在反應完成後,可以讓混合物冷卻至室溫。隨後,減壓以將溶劑從有機層移除,用柱層析純化粗產物,得到4.8g黃色油狀的甲基2-(二苯並[b,d]噻吩-3-基胺)苯甲酸 (75.8%)。1
H NMR (CDCl3
, 400 MHz):化學位移(ppm)8.99(s, 1H),8.14(d, 1H), 7.89(d, 1H), 7.79-7.68(m, 3H), 7.45-7.33(m, 3H), 7.12(m, 1H), 6.97(d, 1H), 6.81(d, 1H), 3.79(s, 3H)。
2-(2-(二苯並[b,d]噻吩-3-基胺)苯基) 2-丙醇的合成
將甲基2-(二苯並[b,d]噻吩-3-基胺)苯甲酸 (4.8 g, 14.4 mmol)的化合物,與50 ml的四氫呋喃(THF)混合。對該混合物,在室溫下,慢慢加入28ml,3M的甲基溴化鎂(CH3
MgBr),得到混合物。接著在室溫下攪拌混合物3小時。在反應完成後,加入氯化銨溶液,得到反應混合物。然後,用乙酸乙酯/水進行萃取,分離出有機層。減壓以將溶劑從有機層移除,用柱層析純化粗產物,得到4.5 g黃色油狀的2-(2-(二苯並[b,d]噻吩-3-基胺)苯基) 2-丙醇(93.7%)。1
H NMR (CDCl3
, 400 MHz):化學位移(ppm) 8.94(s, 1H),7.83(d, 1H), 7.62(d, 1H), 7.55(d, 1H), 7.41-7.36(m, 3H), 7.29(m, 1H), 6.94(m, 1H), 6.78-6.75(d, 2H), 6.59(d, 1H), 3.91(s, 1H), 1.35(s, 6H)。
12,12-二甲基-7,12-二氫苯並[4,5]噻吩[3,2-b]-吖啶的合成
將化合物2-(2-(二苯並[b,d]噻吩-3-基胺)苯基) 2-丙醇(10 g, 30 mmol) ,與150 ml的二氯甲烷(CH2
Cl2
)混合。對此混合物,在室溫下,慢慢加入19 ml的甲基磺酸(CH3
SO3
H)和37 ml的磷酸(H3
PO4
),得到混合物。接著在室溫下攪拌混合物12小時。反應完成後,加入冰水(ice-cold water),得到反應混合物。隨後,將20 %氫氧化鈉溶液加入混合物,然後用乙酸乙酯/水進行萃取,分離出有機層。減壓將溶劑從有機層移除。用柱層析純化粗產物,得到5.3 g黃色固體狀的12,12-二甲基-7,12-二氫苯並[4,5]噻吩[3,2-b]-吖啶 (56%)。1
H NMR (CDCl3
,400 MHz):化學位移(ppm) 8.97(s, 1H),7.81(s, 1H), 7.73(d, 1H), 7.45(d, 1H), 7.38(d, 1H), 7.28(m, 1H), 7.18(dd, 1H), 7.07(m, 1H), 6.89(s, 1H),6.83-6.79(m, 2H), 1.38(s, 6H)。
7-(6-溴芘-1-基)-12,12-二甲基-7,12-二氫苯並[4,5]噻吩[3,2-b]-吖啶的合成
將2.63g(8.33mmol)的12,12-二甲基-7,12-二氫苯-[4,5]-噻吩[3,2-b]-吖啶、3g(8.33mmol)的1,6-二溴芘、0.02g (0.08mmol)的乙酸鈀(Pd(OAc)2
)、1.2g (12.5mmol)的叔丁醇鈉(NaOtBu;sodium tert-butoxide)、及50ml的鄰二甲苯(o-Xylene),五者混合物脫氣並置於氮氣下,然後在140℃加熱12小時。反應完成後,使混合物冷卻至室溫。隨後,將150 ml的甲醇加到混合物中,得到的沉澱物經過濾並用甲醇洗滌,並以管柱層析法純化粗產物,得到黃色固體。產率:1.54 g, 32 %.1
H NMR (CDCl3
, 400 MHz): chemical shift (ppm) 8.33(d, H), 7.89-7.81(m, 3H), 7.54(d, 4H), 7.42(d, H), 7.36-7.32(m, 2H), 7.27(s, H), 7.08-7.03(m, 3H), 6.94(s, H), 6.74(m, H), 6.57(d, H), 1.41(s, 6H)。
6-(12,12-二甲基苯並[4,5]噻吩[3,2-b]吖啶-7(12H)-基)-N,N-雙-對-甲苯芘-1-胺(化合物19)的合成
將1.5 g (2.52 mmol) 7-(6-溴芘-1-基)-12,12- 二甲基-7,12-二氫苯並[4,5]噻吩[3,2-b]吖啶、0.55g (2.77 mmol)的雙-對-甲苯胺、0.006g (0.02mmol)的乙酸鈀(Pd(OAc)2
)、0.36g (3.78mmol)的叔丁醇鈉(NaOtBu;sodium tert-butoxide)、及30ml的鄰二甲苯(o-Xylene),五者混合物脫氣並置於氮氣下,然後在140℃加熱12小時。反應完成後,使混合物冷卻至室溫。隨後,將60 ml的甲醇加到混合物中,得到的沉澱物經過濾並用甲醇洗滌,得到黃色固體。產率:0.86 g, 48 %.1
H NMR (CDCl3
, 400 MHz) :化學位移(ppm) 8.35(d, H), 8.03 (d, H), 7.92(d, H), 7.75(d, 4H), 7.55-7.59(m, 3H), 7.33(s, H), 7.15-7.01(m, 9H), 6.84(m, H), 6.55-6.59(m, 5H), 2.36(s, 6H), 1.42(s, 6H). MS(m/z, EI+
): 710.6。 實施例11-18
我們已使用相同的合成方法得到一系列中間體。所以,以下的化合物(產物),都可以類似地合成而得。
生產有機電激發光元件的方法舉例(GENERAL METHOD OF PRODUCING ORGANIC EL DEVICE)
提供阻值為9~12歐姆/平方(ohm/square)及厚度為120~160 nm的銦錫氧化物塗層玻璃(以下稱為ITO基板),並在超聲波浴(例如洗滌劑、去離子水)中進行多步驟清洗。在氣相沉積有機層之前,通過紫外光(UV)和臭氧進一步處理清洗過的ITO基板。ITO基板的所有預處理過程都在潔淨室(100級)內進行。
在高真空設備下(10-7
Torr)利用電阻加熱的石英舟以氣相沉積將這些有機層依序塗布到ITO基板上。通過石英晶體監視器來精確監控或設定各層的厚度和氣相沉積速率(0.1~0.3 nm/sec)。如上所述,還可以使個別層包含不只一種化合物,即通常摻雜有摻雜材料的主體材料。此可通過來自兩個或多個來源的共氣相沉積成功地實現,表示本發明的雜芳族化合物是熱穩定的。
使用二吡嗪並[2,3-f:2',3'-h]喹喔啉-2,3,6,7,10,11-六腈(dipyrazino[2,3-f:2',3'-h]quinoxaline-2,3,6,7,10,11-hexacarbonitrile)(HAT-CN)形成有機EL組件的電洞注入層。N,N-雙(萘-1-基)-N,N-雙(苯基)-聯苯胺(NPB)最常用來作為電洞傳輸層。10,10-二甲基-13-(3-(芘-1-基)苯基)-10H-茚並[2,1-b]三亞苯 (10,10-dimeth-yl-13-(3-(pyren-1-yl)phenyl)-10H-indeno [2,1-b]triphenylene) (H1) 及10,10-二甲基-12-(4-(芘-1-基)苯基)-10H-茚並[2,1-b]三亞苯 (10,10-dimethyl-12-(4- (pyren-1-yl)phenyl)-10H-indeno[2,1-b]triphenylene) (H2) 可用來作為有機 EL 元件中的發光主體 (emitting host),且N1,N1,N6,N6-四-甲苯芘- 1,6-二胺(D1)可作為藍光客體 (blue guest),以進行對照比較。下列通式所示的化合物HB3用來作為電洞阻擋材料 (hole blocking material;HBM),且 2- (萘-1-基)-9-(4-(1-(4-(10-(萘-2-基)蒽-9-基)苯基)-1H-苯並[d]咪唑-2-基)苯基) -1,10-啡啉 (2-(naphthalen-1-yl)-9-(4-(1-(4-(10-(naphthalene-2-yl)anthracen-9-yl)phenyl)-1H-benzo[d]imidazol-2-yl)phenyl)-1,10-phenanthroline) (ET2) 用來作為電子傳輸材料 (electron transporting material;ETM) 以與 8-羥基喹啉酯基-鋰 (8-hydroxyquinolato -lithium, LiQ) 進行共沉積 (co-deposition)。本發明中用於製作對照和示例性有機EL組件的OLED材料和本發明示例性雜芳族化合物的化學結構,例如,但不限於以下所示:
典型的有機 EL 組件由諸如 Al、Mg、Ca、Li、K 或其合金的低功函數金屬材料所構成,並通過熱蒸鍍方式成為陰極,低功函數金屬可輔助電子從陰極注入至電子傳輸層。此外,為了減少電子注入的屏障,並且改進有機 EL 元件性能,在陰極與電子傳輸層之間引入薄膜電子注入層。電子注入層的常規材料是具有低功函數的金屬鹵化物或金屬氧化物,例如:LiF、LiQ、MgO 或 Li2
O。另一方面,在有機 EL 元件製造之後,通過使用 PR650 光譜掃描光譜儀 (PR650 spectra scan spectrometer) 測量 EL 光譜 (EL spectra) 和 CIE 座標 (CIE coordination)。此外,利用吉時利 2400 可程式化設計電壓-電流源 (Keithley 2400 programmable voltage-current source) 取得電流/電壓 (current/voltage)、發光/電壓 (luminescence/voltage) 及良率/電壓 (yield/ voltage) 的特性。上述設備是於室溫 (約 25℃) 及大氣壓力環境中操作。 實施例19
使用與上述方法類似的過程製作具有下列元件結構(如圖1所示)的發螢光有機EL組件:ITO/HAT-CN(20 nm)/NPB(110 nm)/摻雜5%發光客體材料的發光主體 (30 nm)/HB3/摻雜50% LiQ的ET2(35 nm)/LiQ(1 nm)/Al(160 nm)。在圖1所示的組件中,將電洞注入層(HIL)20(HAT-CN)沉積到透明電極10(ITO)上,將電洞傳輸層30(NPB)沉積到電洞注入層20上,將螢光發光層40(發光主體)沉積到電洞傳輸層(HTL)30上,將電洞阻擋層50(HB3)沉積到螢光發光層40上,將電子傳輸層60(ET2)沉積到電洞阻擋層(HBL)50上,將電子注入層70(LiQ)沉積到電子傳輸層(ETL)60上,並將金屬電極80(Al)沉積到電子注入層70上。將該實施例的有機EL組件的I-V-B(1000 尼特亮度時)等測試報告舉例總結於下表1。。 表1
根據上述示例的有機EL元件的測試報告總結,可知用作發光顏色為藍色之有機EL元件的發光客體材料,表現出比現有技術的材料更多或更佳的性能。舉例來說,本發明使用式(1)的雜芳族化合物作為發光客體材料,來與主體材料例如H1或H2搭配的有機EL元件,可具有較低的驅動電壓、或更高的發光電流效率、或更長的半衰期,或更低的功耗。
總而言之,本發明提供了一種可用於有機EL元件的雜芳族化合物。其中,發光顏色為藍色的有機電激發光元件,可以是優選。該雜芳族化合物可由下式(1)表示:
式(1), X1
可以是二價橋並選自於由O、S、Se、CR4
R5
、NR6
和 SiR7
R8
組成的群組。X2
可以是不存在,也可以是二價橋並選自於由O、S、Se、CR9
R10
、NR11
和 SiR12
R13
組成的群組;其中X2
不存在可以是優選。A可以表示具有2、3、4、5、6、7、8或9個環的經取代或未經取代的稠合環烴單元。m可為0、1、2、3或4的整數。B可表示以下式(2):式(2), 其中環C可以表示苯環,也可以表示具有2、3、4或5個環的的經取代或未經取代的稠合環烴單元。Y可以表示二價橋並選自於由O、S、Se、CR14
R15
、NR16
和SiR17
R18
所組成的群組,其中為S或CR14
R15
可以是優選,且其中R14
和R15
可以是獨立以的為甲基為優選。 式(1)右下方的苯環與(R2
)m
,以及式(1)左下方的苯環與(R1
)m
,最好都不要共同構成下列結構:
根據上述教導顯然可以作出許多的修改及變化。因此,應當瞭解的是,在隨附申請專利範圍的範圍內,可以以本文具體描述的方式以外的其他方式來實施本發明。雖然,本文中已說明並描述了具體實施例,但對於所屬技術領域技術人員來說,顯而易見的是可以在不偏離欲單獨由隨附申請專利範圍限制的情況下對本發明作出許多修改。
10‧‧‧透明電極
20‧‧‧電洞注入層
30‧‧‧電洞傳輸層
40‧‧‧發光層
50‧‧‧電洞阻擋層
60‧‧‧電子傳輸層
70‧‧‧電子注入層
80‧‧‧金屬電極
圖1為本發明的有機EL元件的一個實施方式。
Claims (10)
- 一種以下式(1)的雜芳族化合物:
- 如請求項1所述的雜芳族化合物,其中A表示經取代或未經取代的萘基、經取代或未經取代的菲基、經取代或未經取代的蒽基、經取代或未經取代的芘基、經取代或未經取代的䓛基、經取代或未經取代的三亞苯基、經取代或未經取代的苝基、經取代或未經取代的聯四苯基、經取代或未經取代的7,14-二苯基苊[1,2-k]熒蒽基。
- 如請求項1所述的雜芳族化合物,其中A表示下列化學式中的一種: , 其中,R19 至R24 可獨立為氫原子、具有1至30個碳原子的經取代或未經取代烷基、具有6至30個碳原子的經取代或未經取代芳基、具有6至30個碳原子的經取代或未經取代芳烷基、具有3至30個碳原子的經取代或未經取代雜芳基、及具有6至30個碳原子的經取代或未經取代芳胺基。
- 如請求項1所述的雜芳族化合物,其中該雜芳族化合物為以下化合物中之一化合物: 式(3), 式(4),式(5),式(6), 式(7), 式(8), 式(9), 式(10), 式(11), 式(12),式(13),
- 如請求項1所述的銥複合物,其中該銥複合物為下列化合物中之一化合物:化合物1 化合物2 化合物3 化合物4化合物5 化合物6 化合物7 化合物8化合物9 化合物10 化合物11 化合物12化合物13 化合物14 化合物15 化合物16化合物17 化合物18 化合物19 化合物20化合物21 化合物22 化合物23 化合物24化合物25 化合物26 化合物27 化合物28化合物29 化合物30 化合物31 化合物32化合物33 化合物34 化合物35 化合物36化合物37 化合物38 化合物39 化合物40化合物41 化合物42 化合物43 化合物44化合物45 化合物46 化合物47 化合物48化合物49 化合物50 化合物51 化合物52化合物53 化合物54 化合物55 化合物56化合物57 化合物58 化合物59 化合物60化合物61 化合物62 化合物63 化合物64化合物65 化合物66 化合物67 化合物68化合物69 化合物70 化合物71 化合物72化合物73 化合物74 化合物75 化合物76化合物77 化合物78 化合物79 化合物80化合物81 化合物82 化合物83 化合物84化合物85 化合物86 化合物87 化合物88化合物89 化合物90 化合物91 化合物92化合物93 化合物94 化合物95 化合物96化合物97 化合物98 化合物99 化合物100化合物101 化合物102 化合物103 化合物104化合物105 化合物106 化合物107 化合物108化合物109 化合物110 化合物111 化合物112化合物113 化合物114 化合物115 化合物116化合物117 化合物118 化合物119 化合物120化合物121 化合物122 化合物123 化合物124化合物125 化合物126 化合物127 化合物128化合物129 化合物130 化合物131 化合物132化合物133 化合物134 化合物135 化合物136化合物137 化合物138 化合物139 化合物140化合物141 化合物142 化合物143 化合物144化合物145 化合物146 化合物147 化合物148化合物149 化合物150 化合物151 化合物152化合物153 化合物154 化合物155 化合物156化合物157 化合物158 化合物159 化合物160化合物161 化合物162 化合物163 化合物164化合物165 化合物166 化合物167 化合物168化合物169 化合物170 化合物171 化合物172化合物173 化合物174 化合物175 化合物176化合物177 化合物178 化合物179 化合物180化合物181 化合物182 化合物1783 化合物184化合物185 化合物186 化合物187 化合物188化合物189 化合物190 化合物191 化合物192化合物193 化合物194 化合物195 化合物196化合物197 化合物198 化合物199 化合物200化合物201 化合物202 化合物203 化合物204化合物205 化合物206 化合物207 化合物208化合物209 化合物210 化合物211 化合物212化合物213 化合物214 化合物215 化合物216化合物217 化合物218 化合物219 化合物220化合物221 化合物222 化合物223 化合物224化合物225 化合物226 化合物227 化合物228化合物229 化合物230 化合物231 化合物232化合物233 化合物234 化合物235 化合物236化合物237 化合物238 化合物239 化合物240化合物241 化合物242 化合物243 化合物244化合物245 化合物246 化合物247 化合物248化合物249 化合物250 化合物251 化合物252化合物253 化合物254 化合物255 化合物256化合物257 化合物258 化合物259 化合物260化合物261 化合物262 化合物263 化合物264化合物265 化合物266 化合物267 化合物268化合物269 化合物270 化合物271 化合物272化合物273 化合物274 化合物275 化合物276化合物277 化合物278 化合物279 化合物280化合物281 化合物282 化合物283 化合物284化合物285 化合物286 化合物287 化合物288化合物289 化合物290 化合物291 化合物292化合物293 化合物294 化合物295 化合物296化合物297 化合物298 化合物299 化合物300化合物301 化合物302 化合物303 化合物304化合物305 化合物306 化合物307 化合物308化合物309 化合物310 化合物311 化合物312化合物313 化合物314 化合物315化合物316 化合物317 化合物318化合物319 化合物320 化合物321化合物322 化合物323 化合物324化合物325 化合物326 化合物327化合物328 化合物329 化合物330化合物331 化合物332 化合物333化合物334 化合物335 化合物336化合物337 化合物338 化合物339化合物340 化合物341 化合物342 化合物343化合物344 化合物345 化合物346 化合物347化合物348 化合物349 化合物350 化合物351化合物352 化合物353 化合物354 化合物355化合物356 化合物357,及 化合物358。
- 一種有機電激發光元件,包含由陰極和陽極組成的電極對、及在該電極對之間的發光層及一個或多個有機薄膜層,其中該發光層和該有機薄膜層中的至少一個包含如請求項1所述的雜芳族化合物。
- 如請求項6所述的有機電激發光元件,其中包含式(1)的雜芳族化合物的發光層為螢光客體材料。
- 如請求項6所述的有機電激發光元件,其中包含式(1)的雜芳族化合物的發光層發射藍色的螢光。
- 如請求項6所述的有機電激發光元件,其中該有機電激發光組件為發光面板或背光面板。
- 如請求項1所述的有機電激發光元件,其中該至少一環烴與該共同連接的苯環共同構成萘基、二苯並呋喃基、或二苯並噻吩基。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/961,833 US10844043B2 (en) | 2018-04-24 | 2018-04-24 | Heteroaromatic compound and organic electroluminescence device using the same |
US15/961,833 | 2018-04-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
TW201945515A true TW201945515A (zh) | 2019-12-01 |
TWI719456B TWI719456B (zh) | 2021-02-21 |
Family
ID=68237390
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW108114203A TWI719456B (zh) | 2018-04-24 | 2019-04-23 | 雜芳族化合物及使用該雜芳族化合物的有機電激發光組件 |
Country Status (3)
Country | Link |
---|---|
US (1) | US10844043B2 (zh) |
CN (1) | CN110396061A (zh) |
TW (1) | TWI719456B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111410646A (zh) * | 2019-12-26 | 2020-07-14 | 江西科技师范大学 | 一种9,10-二吡咯基蒽荧光化合物及其制备方法和应用 |
CN112239414B (zh) * | 2020-09-29 | 2022-03-29 | 华南理工大学 | 一类基于2,6-二叔丁基蒽的蓝色有机半导体材料及其制备方法与应用 |
CN113248522B (zh) * | 2021-04-07 | 2023-03-24 | 浙江华显光电科技有限公司 | 一种有机化合物及使用该化合物的有机发光器件 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101647173B1 (ko) * | 2011-12-16 | 2016-08-09 | 주식회사 엘지화학 | 신규한 화합물 및 이를 이용한 유기 발광 소자 |
EP2894155B1 (en) | 2012-09-03 | 2018-11-14 | Hodogaya Chemical Co., Ltd. | Compound having indeno acridan ring structure, and organic electroluminescence element |
US9698351B2 (en) | 2015-04-29 | 2017-07-04 | Feng-wen Yen | Organic material for electroluminescent device |
CN106188026B (zh) * | 2016-07-01 | 2019-03-26 | 中节能万润股份有限公司 | 一类非对称结构有机电致发光材料及其应用 |
CN106831749A (zh) * | 2016-12-20 | 2017-06-13 | 中节能万润股份有限公司 | 一种吩噻嗪类有机电致发光材料及其制备方法和应用 |
US10636977B2 (en) * | 2017-04-14 | 2020-04-28 | Feng-wen Yen | Light emitting material for organic electroluminescence device |
-
2018
- 2018-04-24 US US15/961,833 patent/US10844043B2/en active Active
-
2019
- 2019-04-23 TW TW108114203A patent/TWI719456B/zh active
- 2019-04-24 CN CN201910332672.5A patent/CN110396061A/zh not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
TWI719456B (zh) | 2021-02-21 |
US10844043B2 (en) | 2020-11-24 |
CN110396061A (zh) | 2019-11-01 |
US20190322641A1 (en) | 2019-10-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102239140B (zh) | 茚并芴二酮衍生物、有机电致发光元件用材料及有机电致发光元件 | |
KR101838372B1 (ko) | 유기 전계발광 장치용 인데노트리페닐렌계 아민 유도체 | |
US6984462B2 (en) | Organic electroluminescent devices using double-spiro organic compounds | |
TWI580666B (zh) | Aromatic amine derivatives, organic electroluminescent elements and electronic machines | |
TWI601735B (zh) | 銥金屬錯合物及使用其的有機電激發光裝置 | |
TWI603939B (zh) | 有機材料及使用其的有機電激發光元件 | |
TWI607985B (zh) | 有機材料及使用其的有機電激發光裝置 | |
TWI564272B (zh) | 用於有機電激發光裝置中的化合物及使用該化合物之有機電激發光裝置 | |
TWI564290B (zh) | 有機材料及使用此材料之有機電激發光裝置 | |
TWI668202B (zh) | 有機化合物及使用其的有機電激發光元件 | |
TWI703204B (zh) | 雜芳族化合物及使用其的有機電激發光組件 | |
TWI719456B (zh) | 雜芳族化合物及使用該雜芳族化合物的有機電激發光組件 | |
TWI756542B (zh) | 有機化合物及使用其的有機電激發光元件 | |
CN110218185B (zh) | 杂芳族化合物及使用其的有机电激发光组件 | |
TWI602810B (zh) | 電場發光裝置的有機化合物 | |
KR20160142915A (ko) | 유기 전계 발광 소자용 화합물, 이를 포함하는 유기 전계 발광 소자 | |
TW201706235A (zh) | 有機材料及使用其的有機電激發光元件 | |
KR102472915B1 (ko) | 유기전기 소자용 화합물, 이를 이용한 유기전기소자 및 그 전자 장치 | |
KR100754474B1 (ko) | 안트라센계 유기 발광 화합물 및 이를 포함하는 유기 발광다이오드 | |
KR101779914B1 (ko) | 나프탈렌 유도체 및 이를 포함하는 유기전계발광소자 | |
TW201627261A (zh) | 化合物及使用其的有機電激發光裝置 | |
KR20100005903A (ko) | 페닐-나프틸 유도체 및 이를 사용하는 유기전계발광소자 | |
TWI555749B (zh) | 啡啉衍生物及其用途 | |
TWI766230B (zh) | 有機電致發光材料和器件 | |
CN110010774B (zh) | 有机电致发光器件 |